UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

FOR THE QUARTER ENDED DECEMBER 31, 2018 

COMMISSION FILE NO. 000-30202

FORM 10-Q

 

(Mark One)

[X]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2019

mPhase Technologies, Inc.Or

[  ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________________ to ___________________

Commission File Number 000-30202

mPHASE TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

NEW JERSEYNew Jersey 22-2287503
(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)
incorporation or organization) Identification Number)

688 New Dorp Lane9841 Washingtonian Blvd #390

Staten Island, New York,Gaithersburg, MD

 10306-493320878
(Address of principal executive offices) (Zip Code)

 

973-256-3737

ISSUER’S TELEPHONE NUMBERRegistrant’s telephone number, including area code:(301) 329-2700

 

INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED TO BE FILED BY SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934, DURING THE PRECEDING 12 MONTHS (OR FOR SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED TO FILE SUCH REPORT), AND (2) HAS BEEN SUBJECT TO SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS.Securities registered pursuant to Section 12(b) of the Act: None.

 

YES ☒ NO ☐Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.

[X] Yes [  ] No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

[X] Yes [  ] No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ]Accelerated filer [  ]
Non-accelerated filer(Do not check if a smaller reporting company) [  ]Smaller reporting company [X]
Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) [  ] Yes [X] No

 

THE NUMBER OF SHARES OUTSTANDING OF EACH OF THE REGISTRANT’S CLASSES OF COMMON STOCK AS OF FEBRUARY 14, 2019 IS 56,308,670,154 SHARES, ALL OF ONE CLASS OF NO-PAR VALUE COMMON STOCK.As of February 18, 2020 therewere 13,244,221 shares of the issuer’s common stock, $0.01 par value per share, issued and outstanding.

 

 

 

mPHASE TECHNOLOGIES, INC.

INDEX

 PAGE
   
PART IFINANCIAL INFORMATION

mPhase Technologies, Inc.

Form 10-Q

Table of Contents

  Page
Item 1(Unaudited) Condensed Consolidated Balance SheetsPART IDecember 31, 2018, and June 30, 20181
Unaudited Condensed Consolidated Statements of Operations-Three Months Ended December 31, 2018 and 20172
Unaudited Condensed Consolidated Statements of Operations- Six Months Ended December 31, 2018 and December 31, 20173
Unaudited Condensed Consolidated Statements of Cash Flow-Six Months Ended December 31, 2018 and 2017FINANCIAL INFORMATION4
Item 1.Notes to Unaudited Condensed Consolidated Unaudited Financial Statements54
Item 22.Management’s Discussion and Analysis of Financial Condition and Results of Operations2129
Item 33.Quantitative and Qualitative Disclosures aboutAbout Market Risk3132
Item 44.Controls and Procedures3132
   
PART IIOTHER INFORMATION
33
Item 1.Legal Proceedings3233
Item 1A.Risk Factors33
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds33
Item 3.Defaults Upon Senior Securities37
Item 4.(Removed and Reserved)3733
Item 5.Other Information3733
Item 6.Exhibits and Reports on Form 8-K3733
Signature Page38
SIGNATURES34

 

i

1

 

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact could be deemed forward-looking statements. Statements that include words such as “may,” “will,” “might,” “projects,” “expects,” “plans,” “believes,” “anticipates,” “targets,” “intends,” “hopes,” “aims,” “can,” “should,” “could,” “would,” “goal,” “potential,” “approximately,” “estimate,” “pro forma,” “continue” or “pursue” or the negative of these words or other words or expressions of similar meaning may identify forward-looking statements. For example, forward-looking statements include any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new products, services or developments; any statements regarding future economic conditions or performance; statements of belief and any statement of assumptions underlying any of the foregoing.

These forward-looking statements are found at various places throughout this Quarterly Report on Form 10-Q and the other documents referred to and relate to a variety of matters, including, but not limited to, other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should not be relied upon as predictions of future events and mPhase Technologies, Inc. (the “Company”) cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. Furthermore, if such forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by the Company or any other person that the Company will achieve its objectives and plans in any specified timeframe, or at all.

These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2019, filed with the SEC on October 15, 2019 and elsewhere in this Quarterly Report on Form 10-Q. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report on Form 10-Q. The Company disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this Quarterly Report on Form 10-Q or to reflect the occurrence of unanticipated events, except as required by law.

2

 

mPHASE TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FOR THE THREE AND SIX MONTH PERIOD ENDED DECEMBER 31, 2019

TABLE OF CONTENTS

PAGE
Condensed Consolidated Unaudited Financial Statements:
Consolidated Unaudited Balance Sheets4
Consolidated Unaudited Statements of Operations5
Consolidated Unaudited Statement of Changes in Stockholders’ Deficit6
Consolidated Unaudited Statements of Cash Flows7
Condensed Notes to Consolidated Unaudited Financial Statements9

3

PART I – FINANCIAL INFORMATION

ITEM 1. CONDENSED COSOLIDATED UNAUDITED FINANCIAL STATEMENTS

mPhase Technologies, Inc.

Condensed Consolidated Balance Sheets
(UNAUDITED)

 

  December 31,  June 30, 
  2018  2018 
      
ASSETS      
CURRENT ASSETS      
Cash $348  $261 
         
TOTAL CURRENT ASSETS  348   261 
         
Other assets  800   800 
         
TOTAL ASSETS $1,148  $1,061 
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
CURRENT LIABILITIES        
Accounts payable $341,326  $421,056 
Accrued expenses  167,397   1,131,374 
Due to related parties  32,545   226,045 
Notes payable, Officers’  42,880   777,912 
Notes payable, Director and Investor  4,456   133,274 
Current Portion, Liabilities, in arrears, with convertible features  112,333   997,698 
Current Portion, - Judgement Settlement Agreement (Notes 3 and 5)  300,000   - 
Liabilities of discontinued operations  131,077   306,171 
TOTAL CURRENT LIABILITIES  1,132,014   3,993,530 
         
Long term portion, - Judgement settlement agreement (Notes 3 and 5)  610,764   - 
         
COMMITMENTS AND CONTINGENCIES (Note 5)  -   - 
         
STOCKHOLDERS’ DEFICIT        
Common stock, no par value, 125,000,000,000 shares authorized, 42,704,176,123 and 16,860,514,523 shares issued and outstanding at December 31, 2018 (unaudited) and June 30, 2018, respectively  210,190,956   207,686,223 
Accumulated deficit  (211,932,586)  (211,678,692)
TOTAL STOCKHOLDERS’ DEFICIT  (1,741,630)  (3,992,469)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $1,148  $1,061 
  December 31, 2019  June 30, 2019 
  (Unaudited)    
Assets        
Current Assets        
Cash $106,079  $33,996 
Accounts receivable, net  6,580,980   2,526,155 
Prepaid expenses  2,180   8,820 
Total Current Assets  6,689,239   2,568,971 
Property and equipment, net  10,669   11,048 
Goodwill  6,020   6,020 
Intangible asset - purchased software, net  2,441,549   3,025,801 
Other assets  8,761   3,058 
Total Assets $9,156,238  $5,614,898 
         
Liabilities and Stockholders’ Equity        
Current Liabilities        
Accounts payable $1,797,065  $366,274 
Accrued expenses  4,538,949   3,368,801 
Contract liabilities  115,166   - 
Due to related parties  88,072   65,459 
Notes payable to officers  26,006   25,251 
Convertible notes payable, net  108,618   2,351 
Liabilities in arrears with convertible features  109,000   109,000 
Liabilities in arrears - judgement settlement agreement (Note 7)  784,313   855,660 
Derivative liability  586,073   133,669 
Liabilities of discontinued operations  82,795   82,795 
Total Current Liabilities  8,236,057   5,009,260 
         
Commitments and Contingencies (Note 12)        
         
Stockholders’ Equity        
Preferred stock, $0.01 par value; 1,000 shares authorized, issued and outstanding at December 31, 2019 and June 30, 2019  10   10 

Common stock, $0.01 par value; 100,000,000 shares authorized, 12,667,367 shares issued and 12,493,641 shares outstanding at December 31, 2019, and 11,689,078 shares issued and outstanding at June 30, 2019

  124,936   116,890 
Additional paid-in-capital  230,495,006   214,007,203 
Common stock to be issued  141,225   115,388 
Accumulated other comprehensive income  33,132   - 
Accumulated deficit  (229,874,128)  (213,633,853)
Total Stockholders’ Equity  920,181   605,638 
Total Liabilities and Stockholders’ Equity $9,156,238  $5,614,898 

 

The accompanying notes are an integral part of these condensed consolidated financial statements 


mPHASE TECHNOLOGIES, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

  For the Three Months Ended 
  December 31,
2018
  December 31,
2017
 
       
REVENUES $-  $- 
         
COSTS AND EXPENSES        
         
General and administrative  54,754   37,014 
         
Depreciation and amortization  -   - 
         
TOTAL COSTS AND EXPENSES  54,754   37,014 
         
OPERATING LOSS  (54,754)  (37,014)
         
OTHER INCOME (EXPENSE)        
Interest (Expense)  (24,675)  (60,359)
Gain on debt extinguishments  16,278   - 
TOTAL OTHER INCOME (EXPENSE) $(8,397) $(60,359)
         
Income (Loss) From Continuing Operations, before Income Taxes $(63,151) $(97,373)
         
Income (Loss) From Discontinued Operations  6,902   242,100 
         
Income Taxes  -   - 
         
Net Income (Loss)  (56,249)  144,727 
         
Basic and Diluted Net Income (Loss) per share:        
Income (Loss) per share From Continuing Operations $(0.00) $0.00 
Income (Loss) per share From Discontinued Operations $0.00  $0.00 
Net Income (Loss) per share $(0.00) $0.00 
Weighted Average Number of Shares Outstanding;        
Basic  39,585,434,818   16,730,533,668 
Diluted  39,585,434,818   18,000,000,000 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


4

mPHASE TECHNOLOGIES, INC.mPhase Technologies, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

 

  For the Six Months Ended 
  December 31,
2018
  December 31,
2017
 
       
REVENUES $-  $-
         
COSTS AND EXPENSES        
         
General and administrative  119,223   71,816 
         
Depreciation and amortization  -   683 
         
TOTAL COSTS AND EXPENSES  119,223   72,499 
         
OPERATING LOSS  (119,223)  (72,499)
         
OTHER INCOME (EXPENSE)        
Interest (Expense)  (140,041)  (123,249)
Gain on debt extinguishments  16,278   1,051,594 
TOTAL OTHER INCOME (EXPENSE)  (123,763)  928,345 
         
Loss from Continuing Operations, before Income Taxes $(242,986) $855,846 
         
Income (Loss) from Discontinued Operations  (10,908)  226,001 
         
Income Taxes  -   - 
         
Net Income (Loss) $(253,894) $1,081,847 
         
Basic and Diluted Net Income (Loss) per share:        
Income (Loss) per share From Continuing Operations $(0.00) $0.00 
Income (Loss) per share From Discontinued Operations $(0.00) $0.00 
Net Income (Loss) per share $(0.00) $0.00 
Weighted Average Number of Shares Outstanding;        
Basic  29,049,352,975   17,299,797,272 
Diluted  29,049,352,975   18,000,000,000 
  For the Three Months Ended  For the Six Months Ended 
  December 31,  December 31, 
  2019  2018  2019  2018 
Revenue $7,561,967  $-  $15,131,579  $- 
Cost of revenue  5,623,930   -   11,330,444   - 
Gross Profit  1,938,037   -   3,801,135   - 
Operating Expenses:                
Software development costs  906,423   -   2,110,037   - 
General and administrative expenses  7,122,030   54,754   17,864,051   119,223 
Total Operating Expenses  8,028,453   54,754   19,974,088   119,223 
Operating loss  (6,090,416)  (54,754)  (16,172,953)  (119,223)
Other (Expense) Income:                
Interest expense  (56,787)  (22,049)  (95,653)  (133,908)
Gain on change in fair value of derivative liability  404,597   -   470,400   - 
Initial derivative liability expense  (42,227)  -   (257,803)  - 
Amortization of debt discount  (140,242)  (2,581)  (172,905)  (6,133)
Amortization of deferred financing costs  (6,008)  -   (7,529)  - 
Amortization of original issue discount  (3,681)  -   (3,832)  - 
Gain on debt extinguishments  -   16,278   -   16,278 
Total Other Income (Expense)  155,652   (8,397)  (67,322)  (123,763)
(Loss) income from continuing operations before income taxes  (5,934,764)  (63,151)  (16,240,275)  (242,986)
Income taxes  -   -   -   - 
(Loss) income from continuing operations  (5,934,764)  (63,151)  (16,240,275)  (242,986)
Discontinued operations (Note 13)                
Income (loss) from discontinued operations  -   6,902   -   (10,908)
Net loss $(5,934,764) $(56,249) $(16,240,275) $(253,894)
                 
Comprehensive loss:                
Unrealized (loss) gain on currency translation adjustment  (21,562)  -   33,132   - 
Comprehensive loss $(5,956,326) $(56,249) $(16,207,143) $(253,894)
                 
Loss per common share:                
Loss from continuing operations per common share – basic and diluted $(0.48) $(0.01) $(1.32) $(0.04)
                 
(Loss) income from discontinued operations per common share – basic and diluted $-  $0.00  $-  $(0.00)
                 
Loss per common share – basic and diluted $(0.48) $(0.01) $(1.32) $(0.04)
                 
Weighted average shares outstanding – basic and diluted  12,473,865   7,917,087   12,294,895   5,809,871 

 

The accompanying condensed notes are an integral part of these unaudited condensed consolidated financial statements.


5

mPHASE TECHNOLOGIES, INC.mPhase Technologies, Inc.

Condensed Consolidated Statements of Cash FlowsStockholders’ Equity (Deficit)

For the Six Months Ended December 31, 2019 and 2018

(Unaudited)

 

  For the Six Months Ended 
  December 31, 2018  December 31, 2017 
Cash Flow from Operating Activities:      
Net Income (Loss) from continuing operations $(242,986) $855,846 
Net Income (Loss) from discontinued operations  (10,908)  226,001 
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization  -   683 
Gain on debt cancellation  (28,811)  (1,309,069)
Other non-cash charges for beneficial conversion interest expense  91,177   60,785 
Amortization of loan discount, finance company  6,133   5,284 
Changes in assets and liabilities:        
Prepaid expenses and other current assets  -   (500)
Accounts payable and accrued expenses  81,351   110,548 
Net cash used in operating activities $(104,044) $(50,422)
         
Cash Flow used in Investing Activities:        
Purchase of fixed assets  -   - 
Net Cash used in investing activities  -   - 
         
Cash Flow from Financing Activities:        
Proceeds from issuance of common stock  30,000   13,500 
Repayment of convertible debenture  (8,151)  - 
Proceeds of demand note  -   2,000 
Due to Eagle  -   1,500 
Proceeds from notes payable related parties  82,870   30,395 
Repayment of notes payable related parties  (588)  (226)
Net cash provided by financing activities $104,131  $47,169 
         
Net increase (decrease) in cash  87   (3,253)
         
CASH AND CASH EQUIVALENTS, beginning of period  261   4,163 
CASH AND CASH EQUIVALENTS, end of period $348  $910 
  Preferred Stock  Common Stock  Additional  Common  Accumulated       
  Shares  $0.01 Par Value  Shares  $0.01 Par Value  

Paid in

Capital

  Stock to be Issued  Comprehensive
Income
  

Accumulated

Deficit

  

Stockholders’

Equity

 
Balance June 30, 2019  1,000  $       10     11,689,078  $  116,890  $  214,007,203  $  115,388  $-  $  (213,633,853) $           605,638 
                                     
Issuance of common stock to accredited investors in private placements          380,000   3,800   91,200   (30,500)          64,500 
Issuance of common stock for the conversion of related party debts and strategic vendor payables          294,654   2,947   70,716   (73,663)          - 
Warrants earned under employment contract                  9,970,787               9,970,787 
Other comprehensive income                          54,694       54,694 
Net loss                              (10,305,511)  (10,305,511)
Balance September 30, 2019  1,000  $10   12,363,732  $123,637  $224,139,906  $11,225  $54,694  $(223,939,364) $390,108 
                                     
Issuance of common stock to accredited investors in private placements          10,000   100   2,400   130,000           132,500 
Issuance of common stock for the conversion of related party debts and strategic vendor payables          62,000   620   14,880               15,500 
Restricted shares issued under employment contract          57,909   579   106,078               106,657 
Warrants earned under employment contract                  6,231,742               6,231,742 
Other comprehensive loss                          (21,562)      (21,562)
Net loss                              (5,934,764)  (5,934,764)
Balance December 31, 2019  1,000  $10   12,493,641  $

124,936

  $230,495,006  $141,225  $33,132  $(229,874,128) $920,181 

  Common Stock  Additional       
  Shares  

$0.01 Par

Value

  

Paid in

Capital

  

Accumulated

Deficit

  

Stockholders’

Deficit

 
Balance June 30, 2018  3,372,103  $33,721  $  207,652,502  $  (211,678,692) $      (3,992,469)
                     
Issuance of common stock to accredited investors in private placements  40,000   400   9,600       10,000 
Beneficial conversion feature interest expense charged to additional paid in capital          91,177       91,177 
Issuance of common stock for accrued services  1,150,000   11,500   563,500       575,000 
Issuance of common stock for the conversion of related party debts and strategic vendor payables  3,305,492   33,055   1,619,691       1,652,746 
Net loss              (197,645)  (197,645)
Balance September 30, 2018  7,867,595  $78,676  $209,936,470  $(211,876,337) $(1,861,191)
                     
Reversal of accrued fees from private placements to accredited investors          7,500       7,500 
Issuance of common stock to accredited investors in private placements  80,000   800   19,200       20,000 
Issuance of common stock for the conversion of related party debts and strategic vendor payables  593,240   5,932   142,378       148,310 
Net loss              (56,249)  (56,249)
Balance December 31, 2018  8,540,835  $85,408  $210,105,548  $(211,932,586) $(1,741,630)

 

The accompanying condensed notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

6

 

mPhase Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

  For the Six Months Ended 
  December 31, 
  2019  2018 
Cash flows from operating activities:        
Net loss $(16,240,275) $(253,894)
Adjustments to reconcile net loss to net cash from operating activities:        
Stock-based compensation  16,292,722   - 
Depreciation and amortization  484,278   - 
Initial derivative expense  257,803   - 
Amortization of debt discount  172,905   6,133 
Amortization of deferred financing costs  7,529   - 
Amortization of original issue discount  3,832   - 
Gain on change in fair value of derivative liability  (470,400)  - 
Gain on debt extinguishments  -   (16,278)
Amortization of deferred compensation and beneficial conversion interest expense  -   91,177 
Changes in operating assets and liabilities:        
Increase in accounts receivable  (4,054,825)  - 
Increase in other assets  (5,703)  - 
Decrease in prepaid expenses  6,640   - 
Increase in contract liabilities  115,166   - 
Increase in accounts payable and accrued expenses  2,769,479   243,912 
Net cash (used in) provided by operating activities of continuing operations  (660,849)  71,050 
Net cash used in operating activities of discontinued operations  -   (175,094)
Net cash used in operating activities  (660,849)  (104,044)
         
Cash flows from financing activities:        
Proceeds from issuance of convertible notes payable, net  665,000   - 
Proceeds from sale of common stock, net of finder’s fees  197,000   30,000 
Proceeds from notes payable to related parties  37,800   82,870 
Repayments under settlement agreement  (90,000)  - 
Repayments of convertible notes payable  (78,000)  (8,151)
Repayments of notes payable to related parties  (32,000)  (588)
Net cash provided by financing activities of continuing operations  699,800   104,131 
Net cash provided (used) by financing activities of discontinued operations  -   - 
Net cash provided by financing activities  699,800   104,131 
         
Effect of foreign exchange rate changes on cash  33,132   - 
Net increase in cash  72,083   87 
Cash at beginning of period  33,996   261 
Cash at end of period $106,079  $348 
         
Supplemental disclosure:        
Cash paid for interest $35,053  $9,659 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

7

 
  For the Six Months Ended 
  December 31, 
  2019  2018 
Supplemental disclosure of non-cash operating activities:        
         
Initial fair value of derivative liability recorded as debt discount $

665,001

  $- 
         
Supplemental disclosure of non-cash investing and financing activities:        
         
Issuance of Common Stock for accrued services        
Value $15,500  $575,000 
Shares  62,000   1,150,000 
         
Issuance of Common Stock for the conversion of Related Party debts and Strategic Vendor payables        
Value $73,663  $1,801,056 
Shares  294,654   3,898,732 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

8

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

 

1.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1: NATURE OF BUSINESS AND BASIS OF PRESENTATION

 

NATURE OF OPERATIONSOrganization and Nature of Business

 

mPhase Technologies, Inc. (the “Company”, including its wholly-owned subsidiaries, are collectively referred to herein as “mPhase,” “XDSL”, “Company,” “us,” or “We”)“we.”

The Company was organized on Octoberincorporated in the state of New Jersey in 1979 under the name Tecma Laboratory, Inc. and has subsequently operated under Tecma Laboratories, Inc., and Lightpaths TP Technologies, Inc., until June 2, 1996. Since 20071997 when the Company has been in the business of developing new products through the science of nanotechnology and micro-fluid dynamics. The Company has made significant progress in developing a reserve battery with an unlimited shelf life priorchanged its name to initial activation. Our patent portfolio consists of intellectual property covering the “smart surfaces” that liquids in droplets can be suspended upon and collapse upon initial activation by either an electrical impulse or a g force. The Company intends to develop other potential products such as a drug delivery system using such scientific disciplines to monetize its patent portfolio.

During our last two Fiscal Years ended June 30, 2018 and 2017, the Company has had very limited financial resources to pursue further product development and had fallen behind with respect to our required periodic SEC filings on Forms 10Q and 10K since it lacked resources to pay its auditors. The Company is now current with respect to is SEC filings. We have been negotiating with our creditors to restructure our debt obligations to be in a better position to monetize our patent portfolio. We believe the amendment to the Judgment Settlement Agreement, effective December 10, 2018 by and between John M. Fife, and the Company gives us an opportunity to do so. (see-Note 3. “EQUITY TRANSACTIONS, NOTES PAYABLE AND CONVERTIBLE DEBT”)mPhase Technologies, Inc.

 

On January 11, 2019, the Company underwent a major change in management and focuscontrol. The new management of the Company is positioning the Company to restructurebe a technology leader in artificial intelligence and machine learning while enabling a more rapid commercial development of its business.patent portfolio and other intellectual property. The Company intendsCompany’s goal is to broadengenerate significant revenue from its artificial intelligence and diversify its existing lines of business. The Company will implement is revised plan of operations either directly or through wholly-owned subsidiaries. Such restructuring will include a combination of raising additional capital to improve our balance sheet and aggressive pursuit of mergers and acquisitions.machine learning technologies.

 

On January 11,February 15, 2019, the Company Prior Management and Mr. Anshu Bhatnagar executed contracts includingacquired Travel Buddhi, a transition agreement under which Prior Management was largely replaced. Mr. Bhatnagar becamesoftware platform to enhance travel via ultra-customization tools that tailor a Director and he Company’s new President and CEO andplanned trip experience in ways not previously available.

On June 30, 2019, the Company acquired control99% of the Company. Mr. Durando remainsoutstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a Directorsuite of the Company and Mr. Smiley was reappointed on January 28, 2018 as Chief Financial Officer. It is expected that both Mr. Durando and Mr. Smiley will hold the foregoing positions on an interim basis to provide continuity during the Transition period (SEE NOTE 8- “Subsequent Events”).

The Transition Agreement providescommercial data analysis products for our new management to evaluate, formulate and implement a revised plan of operation.use across multiple industries. The Company is implementing undertakings, initiated by outgoing management,expects the acquisition to extinguish certain debtsresult in synergies with its other operating divisions, which will drive revenue growth and settle or reduce other liabilities outstanding on December 31, 2018, within six (6) months of January 11, 2019. The Company will implement its revised plan of operation either directly or through wholly- owned subsidiaries.innovation.

 

BASIS OF PRESENTATIONBasis of Presentation

 

The accompanying unaudited condensed consolidated unaudited financial information furnished herein reflects all adjustments, consisting only of normal recurring items, which in the opinion of management, are necessary to fairly state the Company’s financial position, results of operations and cash flows for the dates and periods presented and to make such information not misleading. Certain information and footnote disclosures normally included in annual financial statements have been prepared in accordance with accounting principles generally accepted accounting principles for interim financial information andin the United States of America (“US GAAP”) have been omitted pursuant to therules and regulations of the Securities and Exchange Commission. Accordingly, they do not include allCommission (the “SEC”); nevertheless, management of the Company believes that the disclosures herein are adequate to make the information and footnotes required by generally accepted accounting principles for completepresented not misleading.

The condensed consolidated unaudited financial statements. In the opinion of management, all adjustments (normal and recurring in nature) considered necessary for a fair presentation have been included. Operating resultsstatements for the six months ended ending December 31, 2019 and 2018 are not necessarily indicativeinclude the operations of mPhase and its wholly-owned subsidiaries, mPower Technologies, Inc., Medds, Inc., mPhase Technologies India Private Limited effective March 19, 2019, and Alpha Predictions LLP effective June 30, 2019. All significant intercompany accounts and transactions have been eliminated in the results that may be expected for a full fiscal year. The accompanying unauditedconsolidation.

These condensed consolidated unaudited financial statements should be read in conjunction with the Company’s audited consolidated financial statements and footnotes thereto includedfor the year ended June 30, 2019, contained in the Company’s Annual Report on Form 10-K as amended,filed with the SEC on October 15, 2019. The results of operations for the six months ended December 31, 2019, are not necessarily indicative of results to be expected for any other interim period or the fiscal year endedending June 30, 2018.2020.

 

9

GOING CONCERN

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

 

NOTE 2: GOING CONCERN

The Company’saccompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

Through December 31, 2018, theThe Company hadhas incurred (a) cumulative losses totaling ($211,932,586) and (b) a stockholders’ deficitnegative cash flows from operations of ($1,741,630). At December 31, 2018, the Company had $348 of cash to fund short-term working capital requirements and cash used in operating activities was ($104,218)$660,849 for the six months ended December 31, 2018. In addition,2019. At December 31, 2019, the Company relies on the continuationhad a working capital deficit of funding through private placements$1,546,818, and an accumulated deficit of its common stock. These matters$229,874,128. It is management’s opinion that these facts raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this quarterly report.report, without additional debt or equity financing. The accompanying condensedunaudited consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts nor to the amounts and classification of liabilities that might result frombe necessary should the outcome of this uncertainty.


1.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

GOING CONCERN – (continued)

The Company’s abilityCompany be unable to continue as a going concernconcern.

In order to meet its working capital needs through the next twelve months from the date of this report and its future success is dependent upon its abilityto fund the growth of our nanotechnology, artificial intelligence, and machine learning technologies, the Company may consider plans to raise capital inadditional funds through the near term to: (1) satisfyissuance of equity or debt. Although the Company intends to obtain additional financing to meet its current obligations, including recently amended settlement agreements, (2) continue its plancash needs, the Company may be unable to align partners or other third parties to underwritesecure any research and development efforts needed to exploit our existing technological capabilities, or develop new products and (3) allow the successful wide scale development, deployment and marketing of its smart surface products, or any newly developed, acquired or otherwise obtained product or service line of business. There can be no assurance the necessary debt or equityadditional financing will be available, or if so, on terms that are favorable or acceptable to the Company.it, if at all.

 

RECLASSIFICATIONSNOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Certain reclassifications have been madeForeign Currency Translation and Transactions

The functional currency of our operations in India is the priorIndian Rupee. Foreign currency denominated assets and liabilities are translated into U.S. dollars at the exchange rates in effect at the balance sheet date, and income and expense items are translated at the average exchange rates in effect during the applicable period. Translation adjustments arising from the use of different exchange rates from period consolidated financial statements to conform to the current period presentation. The Company reclassified accrued fees of $1,500 to Eagle Advisors to a source of funds from financing activities previouslyare included as a sourcecomponent of funds in operating activitiesstockholders’ equity as “Accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the Statementconsolidated statements of Cash Flowscomprehensive income (loss), as other comprehensive income (loss). There have been no significant fluctuations in 2017. The reclassified financial statement items had no effect on Net Income (Loss)the exchange rate for the Quarter, Total Stockholders’ Deficit or Total Assets forconversion of Indian Rupee to U.S. dollars after the three months ended December 31, 2018 and 2017.balance sheet date.

 

USE OF ESTIMATESUse of Estimates

 

The preparation of condensed consolidated unaudited financial statements in conformity with generally accepted accounting principlesUS GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. These estimates include net realizable value of inventories, estimated value of stock-based compensation and changes in and the ending fair value of derivative liability.period. Actual results could differ from those estimates. If actual results significantly differ from the Company’s estimates, the Company’s financial condition and results of operations could be materially impacted. Significant estimates include the collectability of accounts receivable, valuation of intangible assets, accrued expenses, valuation of derivative liabilities, stock-based compensation, and the deferred tax asset valuation allowance.

 

LOSS PER COMMON SHARE, BASIC AND DILUTEDConcentrations of Credit Risk

 

Basic income (loss) per share is computed by dividing net income (loss)Credit Risk

Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with three financial institutions. Deposits held with the financial institutions may exceed the amount of insurance provided by the weighted average numberFederal Deposit Insurance Corporation on such deposits, but may be redeemed upon demand. The Company performs periodic evaluations of sharesthe relative credit standing of common stock outstanding during the period. Diluted earnings per share is computed by dividing net loss adjustedfinancial institutions. With respect to accounts receivable, the Company monitors the credit quality of its customers as well as maintain an allowance for income or loss that would resultdoubtful accounts for estimated losses resulting from the assumed conversioninability of potential common shares from contracts that maycustomers to make required payments.

Revenue Risk

Agreements which potentially subject the Company to concentrations of revenue risk consist principally of one customer agreement. For the six months ended December 31, 2019 and 2018, this one customer accounted for 99% and 0% of our total revenue, respectively. At December 31, 2019 and June 30, 2019, this one customer accounted for 96% and 99% of our total accounts receivable, respectively.

Cash and Cash Equivalents

For purposes of balance sheet presentation and reporting of cash flows, the Company considers all unrestricted demand deposits, money market funds and highly liquid debt instruments with an original maturity of less than 90 days to be settled in stock or cash by the weighted average number of shares of common stock, common stockand cash equivalents. There were no cash equivalents and potentially dilutive securities outstanding during each period. The Company had no warrants to purchase shares of its common stock and no options to purchase shares of its common stock outstanding at December 31, 2018.2019 and June 30, 2019.

 

10

At December

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018 the Company has convertible securities held by third parties that are immediately convertible into 160,499,917 shares of common stock. Under the terms of the judgement settlement agreement with Mr. Fife, effective December 10, 2018 there are no features whereby the debt would convertible in shares of the Company’s common stock; In addition, the Company has convertible notes plus accrued interest thereon held by officers and a Director of the Company, subject to availability, convertible into approximately 872,160,000 shares of common stock, immediately.

(UNAUDITED)

 

The following table illustrates debts convertible into shares of the Company’s Common Stock at December 31, 2018:

  December 31, 2018 
  (Unaudited) 
  Note
Principle
  Accrued
Interest
  Total  Shares Convertible 
          immediately  conditionally available 
Arrangement #1 - JMJ Financial, Inc $109,000  $76,733  $185,733   46,433,250   - 
Arrangement #2 - St. George Investments/Fife Forbearance Obligation      -   -(i)  -   - 
Arrangement #3 - MH Investment trust II  3,333   3,511   6,844   114,066,667   - 
Total Liabilities, in arrears, with convertible features  112,333   80,244   192,577   160,499,917   - 
 Judgement Settlement Agreement  910,764       910,764(i)        
Notes Payable- Officers  42,880   -   42,880(ii)  -   857,600,000 
Notes Payable- Director  1,456   -   1,456(ii)  -   14,560,000 
Total $1,067,433  $80,244  $1,147,677   160,499,917   872,160,000 

(i)The Judgement Settlement Agreement with Mr. Fife, effective December 10, 2018 has no features whereby the debt is convertible into our common stock on December 31, 2018.(SEE NOTE 3 - Judgement Settlement Agreement)
(ii)Conditionally convertible if available under “Settlements Reserve”, through July 11, 2019. (SEE NOTE 3 - Reserved Shares)

1.BASIS OF PRESENTATION ANDNOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

DISCONTINUED OPERATIONS

The Company has classified the operating results and associated assets and liabilities from its Jump line of products, which ceased having material sales in the first quarter of Fiscal 2017, as Discontinued Operations in the Consolidated Financial Statements for the Fiscal Years ended June 30, 2018 and 2019.

The Assets and Liabilities associated with discontinued operations included in our Consolidated Balance Sheet were as follows:

  December 31, 2018  June 30, 2018 
  (Unaudited)          
  Total  Discontinued  Continuing  Total  Discontinued  Continuing 
ASSETS                  
CURRENT ASSETS                        
Cash $348   -   348  $261   -   261 
TOTAL CURRENT ASSETS  348       348   261       261 
                         
Other assets  800   -   800   800   -   800 
                         
TOTAL ASSETS $1,148       1,148  $1,061       1,061 
                         
LIABILITIES AND STOCKHOLDERS’ DEFICIT                        
CURRENT LIABILITIES                        
Accounts payable $426,802   85,476   341,326  $545,564   124,508   421,056 
Accrued expenses  167,397   -   167,397   1,273,569   142,195   1,131,374 
Due to related parties  32,545   -   32,545   226,045   -   226,045 
Notes payable, Officers’  42,880   -   42,880   777,912   -   777,912 
Notes payable, Director and Investor  4,456   -   4,456   133,274   -   133,274 
Note Payable, Finance Company  45,601   45,601   -   39,468   39,468   - 
Current Portion, Liabilities, in arrears, with convertible features  112,333   0   112,333   0   0   0 
Current Portion, Judgement Settlement Agreement (Notes 3 and 5)  300,000   -   412,334   997,698   -   997,698 
TOTAL CURRENT LIABILITIES  1,132,014   131,077   1,000,938   3,993,530   306,171   3,687,359 
                         
                         
Long term portion, Convertible debenture(under settlement agreement-Note 5)  610,764   -   610,763   -   -   - 
                         
TOTAL LIABILITIES $1,742,778   131,077   1,611,701  $3,993,530   306,171   3,687,359 

7

1.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

DISCONTINUED OPERATIONS – (continued)

 

Revenue and Expense Recognition for Discontinued OperationsAccounts Receivable

 

The Company had recognized revenue onregularly reviews outstanding receivables and provides for estimated losses through an allowance for doubtful accounts. In evaluating the level of established loss reserves, the Company makes judgments regarding its JUMP products whencustomers’ ability to make required payments, economic events and other factors. As the products were shipped, and title passedfinancial condition of these parties change, circumstances develop or additional information becomes available, adjustments to the customer.  

allowance for doubtful accounts may be required. The results of discontinued operations include only specifically identified in the three-monthCompany maintains reserves for potential credit losses and six-month periods endedsuch losses traditionally have been within its expectations. At December 31, 20182019 and both specifically identified and allocated common overhead expenses inJune 30, 2019, the period ended December 31, 2017.Company determined there was no requirement for an allowance for doubtful accounts.

 

The expensesGoodwill and items of other income associated with discontinued operations included in our QUARTERLY condensed Consolidated Statements of operations were as follows:Intangible Assets

 

  For the Three Months Ended 
  December 31,
2018
  December 31,
2017
 
  Discontinued  Discontinued 
REVENUES $-  $- 
         
COSTS AND EXPENSES        
         
Selling and Marketing  -   670 
         
General and administrative  -   4,561 
         
Depreciation and amortization  -   - 
         
TOTAL COSTS AND EXPENSES  -   5,231 
         
OPERATING LOSS  -   (5,231)
         
OTHER INCOME (EXPENSE)        
Interest (Expense)  (5,631)  (10,144)
Gain on debt extinguishments  12,533   257,475 
         
TOTAL OTHER INCOME (EXPENSE) $6,902  $247,331 
         
Income from Discontinued Operations $6,902  $242,100 

PATENTS AND LICENSESGoodwill is recorded when the purchase price paid for an acquisition exceeds the fair value of the net identified tangible and intangible assets acquired. The Company evaluates goodwill for impairment annually or more frequently when an event occurs or circumstances change that indicate that the carrying value may not be recoverable. The Company tests goodwill for impairment by first comparing the fair value of the reporting unit to its carrying value. If the fair value is determined to be less than the carrying value, a second step is performed to measure the amount of impairment loss. On June 30, 2020, we will perform our annual evaluation of goodwill impairment to determine if the estimated fair value of the reporting unit exceeds its carrying value.

 

Patents and licenses are capitalized when mPhasethe Company determines there will be a future benefit derived from such assets and are stated at cost. Amortization is computed using the straight-line method over the estimated useful life of the asset, generally five years. As of December 31, 2018,2019, and June 30, 2019, the book value of such assets, orpatents and licenses of $214,383, has been fully amortized.


1.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

DISCONTINUED OPERATIONS – (continued)

The expensesamortized and items of other income associated with discontinued operations included in our SIX-MONTH CONDENSED Consolidated Statements of operations were as follows:

  For the Six Months Ended 
  December 31,
2018
  December 31,
2017
 
  Discontinued  Discontinued 
REVENUES $-  $- 
         
COSTS AND EXPENSES        
         
Selling and Marketing  -   2,094 
         
General and administrative  -   8,863 
         
Depreciation and amortization  -   - 
         
TOTAL COSTS AND EXPENSES  -   10,957 
         
OPERATING LOSS  -   (10,957)
         
OTHER INCOME (EXPENSE)        
Interest (Expense)  (23,441)  (20,517)
Gain on debt extinguishments  12,533   257,475 
TOTAL OTHER INCOME (EXPENSE)  (10,908) $236,958 
         
Income (Loss) from Discontinued Operations $(10,908) $226,001 

Recently Issued Accounting Pronouncements

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 establishes a single comprehensive modelno amortization expense was recorded for entities to use in accounting for revenue arising from outside contracts with customers and supersedes most of the existing revenue recognition guidance and notes that lease contracts with customers are a scope exception. ASU 2014-09 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services and also requires certain additional disclosures. On August 12, 2015, the FASB issued ASU 2015-14 to defer the effective date of ASU 2014-09. Public business entities may elect to adopt the amendments as of the original effective date, however, adoption is required for annual reporting periods beginning after December 15, 2017. The Company will implement this pronouncement on July 1, 2019.

In January 2016, the FASB issued ASU-2016-01, Financial Instruments- Overall (Subtopic 825-10) Recognition and Measurement of Financial Assets and Financial Liability Letters. The Company is currently assessing the impact of the guidance on our financial statements and notes to our financial statements.


In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”). The standard amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective beginning in the first quarter of fiscal 2020. Early adoption of ASU 2016-02 is permitted. The new leases standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. In September, the FASB issued ASU 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842) which amends certain aspects of the new lease standard. The Company is currently evaluating the impact of adopting ASU 2016-02 on the Company’s financial statements.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The new standard changes the presentation of restricted cash and cash equivalents on the statement of cash flows. Restricted cash and restricted cash equivalents will be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. Early adoption is permitted. This ASU is not expected to have a material impact on the Company’s financial statements.

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business.” The amendments in this Update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of businesses. The amendments in this Update provide a screen to determine when a set is not a business. If the screen is not met, it (1) requires that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) removes the evaluation of whether a market participant could replace the missing elements. This Update is the final version of Proposed ASU 2015-330 Business Combinations (Topic 805) – Clarifying The Definition of a Business, which has been deleted. The amendments in this Update are effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. Early adoption is permitted. This ASU is not expected to have a material impact on the Company’s financial statements.

In May 2017, the FASB issued ASU 2017-09, “Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting” to provide clarity and reduce both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, Compensation—Stock Compensation, to a change to the terms or conditions of a share-based payment award. The amendments in this Update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. This Update is the final version of Proposed ASU 2016-360—Compensation—Stock Compensation (Topic 718)—Scope of Modification Accounting, which has been deleted. The amendments in this Update are effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. Early adoption is permitted. This ASU is not expected to have a material impact on the Company’s financial statements.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on the accompanying abbreviated financial statements.

2.SUPPLEMENTAL CASH FLOW INFORMATION

Statement of Operation Information:      
Interest paid (net interest income) $9,659  $1,816 
         
Non-Cash Investing and Financing Activities:        
Conversion of accrued wages Officers’ into 5,387,770,000 shares of common stock $538,777  $- 
Conversion of Officers’ loans and accrued interest thereon into 9,593,875,000 shares of common stock $830,746  $- 
Conversion of accrued fees to a Director into 1,860,000,000 shares of common stock $186,000  $- 
Conversion of loans and accrued interest thereon into 1,351,017,700 shares of common stock $130,733  $- 
Conversion of accounts payable to strategic vendors into 1,301,000,000 shares of common stock $114,800  $- 
Conversion of accrued stock award’ into 5,750,000,000 shares of common stock $575,000  $- 

3.EQUITY TRANSACTIONS, NOTES PAYABLE AND CONVERTIBLE DEBT

Common Stock

On December 18, 2018 the Company’s Board approved a resolution to increase the authorized common shares of the Company to 125 billion shares of the Company’s common stock no par value. January 4, 2019 the State of New Jersey accepted an Amendment to the Company’s Certificate of Incorporation providing for the increase in authorized shares of common stock and the change to no par value.

Preferred Stock

Additionally, on December 18, 2018 the Board approved a new class of 1000 shares of Series A (super voting preferred stock). On January 4, 2019 the State of New Jersey accepted an Amendment to the Company’s Certificate of Incorporation providing for the new class of super voting preferred stock. The shares of the new Series A voting preferred stock provide for 51% of the voting authority of all capital stock; feature no dividends, have a Par Value $.001 per share and have a liquidation preference up to Stated Value (Par) of $.001 per share. All the 1000 shares of the Series A Preferred Stock were issued to the Company’s New President and CEO to effectuate voting control of the Company on January 11, 2019, pursuant to the Transition Agreement. (See “Subsequent Events”).

Private Placements

During the six months ended December 31, 2018,2019 and 2018.

Capitalized Software Development Costs

The Company follows the provisions of ASC 350-40, “Internal Use Software.” ASC 350-40 provides guidance for determining whether computer software is internal-use software, and on accounting for the proceeds of computer software originally developed or obtained for internal use and then subsequently sold to the public. It also provides guidance on capitalization of the costs incurred for computer software developed or obtained for internal use. The Company issued 600,000,000 sharesexpenses all costs incurred during the preliminary project stage of its common stock in connection with private placements pursuantdevelopment, and capitalizes the costs incurred during the application development stage. Costs incurred relating to Section 4(a) (2) ofupgrades and enhancements to the Securities Act of 1933,software are capitalized if it is determined that these upgrades or enhancements add additional functionality to the software. Costs incurred to improve and support products after they become available are charged to expense as amended, raising gross proceeds of $30,000. The proceeds were used by the Company as working capital.incurred.

 

DuringCapitalized software development costs are amortized on a straight-line basis over the estimated useful lives, currently three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets.

At December 31, 2019, the book value of purchased and developed technology of $2,925,827, included two technology platforms, a machine learning platform and an artificial intelligence platform. For the six months ended December 31, 2017,2019 and 2018, amortization expense which is included in general and administration expenses within the Company issued 300,000,00 sharesconsolidated statements of its common stock in connection with private placements pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, raising gross proceeds of $15,000operations, was $484,278 and incurring finder’s fees of $1,500. The proceeds were used by the Company as working capital.$0, respectively.

 

Stock Award Payable

During the six months ended December 31, 2018, the three OfficersFair Value of the Company received 4,000,000,000 shares of common stock which were valued at $400,000, Mr. Biderman an outside Director received 1,000,000,000 shares of common stock which were valued at $100,000 and strategic consultants received 750,000,000 shares of common stock which were valued at $75,000, and in total this group received a total of 5,750,000,000 shares of common stock which was valued at $575,000 and had been included in accrued expenses at June 30, 2018. 

Stock Based Compensation

During the six months ended December 31, 2018, the Company did not issue any common stock, other than the shares discussed above whish were awarded in fiscal 2018, warrants or options to employees or officers.

During the six months ended December 31, 2017, the Company did not issue any common stock, warrants or options to employees or officers.

Other Short-Term Notes 

Note Payable, Director

A Director of the Company loaned the Company funds for working capital and through June 30, 2018 $130,274 remained outstanding. On September 24, 2018 and December 31, 2018, this director converted $126,364 and $4,369 of this note into 1,263,642,700 and 87,375,000 shares of common stock, on the respective dates; and as a result, $1,456 remained outstanding on December 31, 2018. During the six months ended December 31, 2018 and 2017 the Company recorded $1,915 and $3,755 of accrued interest on this loan.

Note payable - Investor

During the fourth quarter fiscal 2017 an unaffiliated shareholder advanced the Company $1,000. During fiscal 2018 the shareholder advanced an additional $2,000. At December 31, 2018 and June 30, 2018 $3,000 remained outstanding under this note.

Note Payable, Finance Company- Discontinued OperationsFinancial Instruments

 

The Company borrowed approximately $66,000 from a finance company under two advances commencing January 2016, with scheduled repayments of approximately $87,500 originally due through July 2016. This note is in arrears and the Company is negotiating settlement terms with the Note Holder.

During the six months ended December 31, 2018 and 2017 we incurred $6,133 and $5285 of finance charges under this note and at December 31, 2018, $45,601 remained outstanding.

11

3.EQUITY TRANSACTIONS, NOTES PAYABLE AND CONVERTIBLE DEBT – (continued)

Liabilities, in arrears, with Convertible Features / Judgement Settlement Agreement

The Company had three separate convertible debt arrangements with independent investors that still, had convertible features as of June 30, 2018, The Company had two separate convertible debt arrangements with independent investors that still, had convertible features as of December 31, 2018.

During the six months ended December 31, 2018 no conversions were made under any Convertible Debentures.

During the six months ended December 31, 2017, no conversions were made under any Convertible Debentures.

The following table summarizes Liabilities, in arrears, with current or past convertible features:

  December 31,  June 30, 
  2018  2018 
       
Arrangement #1 - JMJ Financial, Inc $109,000  $109,000 
Arrangement #2 - St. George Investments/Fife Forbearance Obligation  -   885,365 
Arrangement #3 - MH Investment trust II  3,333   3,333 
Total Liabilities, in arrears, with convertible features  112,333   997,698 
Liabilities, in arrears, -Judgement Settlement Agreement (Formerly Fife Forbearance Obligation)  910,764   - 
Total Liabilities, in arrears, with convertible features (or formerly convertible) $1,023,097  $997,698 
Liabilities, in arrears, -short term portion $412,333  $997,698 
Long Term Portion, Liabilities, in arrears, -Judgement Settlement Agreement $610,764  $- 

Included in accrued expenses is $80,244 and $72,638 of interest accrued on the liabilities, in arrears, with convertible features at December 31, 2018 and June 30, 2018, respectively.

These transactions were initially intended to provide liquidity and capital to the Company and are summarized below.

Arrangement #1 (JMJ Financial, Inc.)

The Company entered into a convertible note on November 17, 2009, in which the Company received a total of $186,000 of proceeds in connection with a new financing agreement with JMJ Financial. This transaction consists of the following: 1) a convertible note in the amount of $1,200,000 plus a one-time interest factor of 12% ($144,000) and a maturity date of September 23, 2012 and (2) a secured promissory note in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000 each) and a maturity date of September 23, 2012 due from the holder of the convertible note, of which the Company received a total of $150,000 of proceeds in connection with the second promissory note under this agreement. At June 30, 2012 this convertible note had $372,060 outstanding which was combined with the April 5, 2010 arrangement with JMJ Financial, Inc. JMJ Financial sold this Note to River North Equity LLC. On December 15, 2009 the Company entered into a new financing agreement with JMJ Financial that consists of the following: 1) a convertible note issued by the Company in the amount of $1,500,000 plus a one-time interest factor of 12% ($180,000) and a maturity date of December 15, 2012 and (2) a secured promissory note in the amount of $1,400,000 plus a one-time interest rate factor of 13.2% ($180,000) and a maturity date of December 15, 2012 due from the holder of the convertible note. To date the Company has received a total of $300,000 cash under this note and has issued no shares of common stock to the holder upon conversions. The Company and the holder entered into a Forbearance Agreement amendment, as amended, and funding and conversions have not occurred since April 2011. As of June 30, 2012, this convertible note had $321,000 outstanding which was combined with the April 5, 2010 arrangement with JMJ Financial, Inc. JMJ Financial also sold this Note to River North Equity LLC.


3.EQUITY TRANSACTIONS, NOTES PAYABLE AND CONVERTIBLE DEBT – (continued)

Arrangement #1 (JMJ Financial, Inc.) – (continued)

On April 5, 2010, the Company entered into a financing agreement with JMJ Financial that consists of the following: 1) a convertible note issued by the Company in the principal amount of $1,200,000 plus a one-time interest factor of 12% ($144,000) and a maturity date of December 15, 2012, and (2) a secured promissory note from the holder of the convertible note in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000 each) and a maturity date of December 15, 2012. To date the Company has received a total of $100,000 cash under this note and has issued no shares of common stock to the holder upon conversions.

The remaining $1,144,000 of cash to be received from the holder plus accrued and unpaid interest is convertible into shares of common stock at the option of the holder. As of June 30, 2012, this convertible note had $109,000 outstanding which was combined with the November 17, 2009 and December 15, 2009 arrangements with JMJ Financial, Inc., for a total of $802,060 for convertible notes. The Company has no promissory notes receivable from JMJ as of June 30, 2012.

In April of 2017, the Company received a judgment from the Federal District Court of Northern Illinois Eastern Division in its favor dismissing a claim by River North Equity which effectively negated two notes River North Equity purchased from JMJ Financial. At June 30, 2017 the amount recorded in Current Liabilitiesaccounts for the two notes and accrued interest thereon subject to the River North Equity claim was $1,046,416. Such amount is included in the amount recorded in Current Liabilities for all three convertible notes and accrued interest thereon previously issued to JMJ Financial which totaled $1,212,940 on that date. River North failed to appeal the Judgement by July 17, 2017 and the Judgement become final. As a result of this proceeding the Company recorded the cancellation of the two notes assigned to River North from JMJ Financial for a total of $693,060 of principal and $358,534 accrued interest thereon. This resulted in a $1,051,594 gain from the debt during the six months ended December 30, 2017.

As of December 31, 2018, and as of June 30, 2018, the aggregate remaining amount of convertible securities held by JMJ could be converted into 46,433,250 and 44,630,000 common shares at the conversion floor price of $.004.

During the six months ended December 31, 2018 and 2017 the Company recorded $7,212 and $9,198 interest on this agreement.

At June 30, 2018 the amount recorded in Current Liabilities for all three convertible notes and accrued interest thereon previously issued to JMJ Financial was $109,000 and $69,520, respectively. At December 31, 2018 the amount recorded in Current Liabilities for convertible note plus accrued interest thereon previously issued to JMJ Financial was $109,000 and $76,733 respectively.

Arrangement #2 (John Fife dba St. George Investors)/Fife Forbearance

The Company entered into an amended agreement on June 1, 2012, when principle of $557,500 accrued interest of $66,338 and $95,611 of contractual charges for previous notes with John Fife totaled $719,449; whereby, the Company agreed to make payments of principle and interest of $33,238 per month commencing October 1, 2012 through September 1, 2014 at 8% interest and so long as the payments are not in default then no conversions into the Company’s common stock would be available to the holder.

On November 20, 2012, mPhase Technologies, Inc. (the “Company”) formally received an Event of Default and Redemption Notice dated November 16, 2012 with respect to an 8% Convertible Note dated September 13, 2011 issued by the Company to St. George Investments LLC and assigned to John Fife. The notice included alleged defaults with respect to payments owed by the Company under the Convertible Note and the failure to convert the Note into shares of the Company’s common stock. The alleged amount owed according to the notice at that time was approximately $902,279. This proceeding resulted a Memorandum Opinion and Order which was issued on December 15, 2014 by the United States District Court Northern District of Illinois Eastern Division granting the motion of John Fife, plaintiff (“Plaintiff”), for summary judgment against mPhase Technologies, Inc. (the “Company”) for breach of contract (the “Opinion”). All other claims and counterclaims were dismissed. Effective February 10, 2015, the Company entered into a Forbearance Agreement with the Holder. The agreement provided that the Holder would forego his right to enforce its remedies pursuant to the Judgment, which include demand for immediate payment of approximately $1.6 million, provided the Company satisfy its forbearance obligation of $1,003,943, (after accounting for a payment of $15,000 the Company paid, under the terms of the agreement).

The Forbearance agreement required the Company to place, and the Company had done so, 1,000,000,000 shares in reserve with its transfer agent, to satisfy the conversion provisions for any unpaid monthly cash payments. The original agreement also provided that the Company file a Proxy statement before June 1, 2015 should additional shares be needed for the conversion reserve. The Company has not filed such a proxy statement due to cost prohibitions. As of June 30, 2018, 1,000,000,000 shares have been issued with respect to payment obligations under the forbearance agreement, as amended and no amounts remain, in reserve,

On various occasions commencing with August 11, 2015 and then January 19, 2016, June 30, 2016, August 18, 2017 and February 16, 2018 the Company entered into an Amendments No. 1 through 5 to the Forbearance Agreement with Mr. Fife; primarily rescheduling the monthly payment schedules.

As of June 30, 2017, this forbearance obligation, as amended, would only be convertible for monthly obligations the Company elects to/or does not pay in cash in part or in full, for: (i) up to 625,000,000 shares, for the satisfaction of the next required monthly payment, and (ii) up to 10,123,399,750 shares of our common stock should the entire obligation be converted.


3.EQUITY TRANSACTIONS, NOTES PAYABLE AND CONVERTIBLE DEBT – (continued)

Arrangement #2 (John Fife dba St. George Investors)/Fife Forbearance – (continued)

During the year ended June 30, 2018 the Company did not make any repayments to Fife under the Judgment Settlement Agreement, as amended. Thefair value of the forbearance debt obligation on June 30, 2018 was $885,365.

As of, June 30, 2018, this forbearance obligation,financial instruments in accordance with ASC topic 820, “Fair Value Measurements and Disclosures” (ASC 820), formerly SFAS No. 157 “Fair Value Measurements”. ASC 820 defines “fair value” as amended, would only be convertible for monthly obligations the Company elects to/or does not pay in cash in part or in full, for: (i) up to 625,000,000 shares, for the satisfaction of the next required monthly payment, and (ii) up to 11,067,050,000 shares of our common stock should the entire obligation be converted.

The Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife discussed above, effective December 10, 2018.As of December 31, 2018, the Forbearance agreement is no longer in effect and no shares of our common stock are issuable or eligible to be converted to under this obligation.

Arrangement #3 (MH Investment trust II)

On August 26, 2014, the Company issued to the MH Investment Trust, a Convertible Note in a Private Placement pursuant to Section 4(2) of the Securities Act of 1933 in which the Company received $40,000 in gross proceeds on September 1, 2014. The instrument is in the principal amount of $40,000 and matured on May 1, 2015. Interest only was payable at the rate of 12% per annum by the Company to the holder until maturity. The instrument is convertible into the Company’s common stock at 60% of the volume weighted average price of the stock based upon the average of the three lowest trading days in the 10day trading period immediately preceding such conversion, or 65 % when the trading price exceeds $.0020 for the five days before such conversion. All proceeds received in connection with the proceeds of the financing used by the Company as working capital.

During the six months ended December 31, 2018 and 2017 the Company recorded $393 and $352 interest on this agreement.

At December 31, 2018 the note balance was $3,333 and accrued interest of $3,511 at 12%, remained due under this agreement. At June 30, 2018 the note balance was $3,333 and accrued interest of $3,118, at 12%; remained due under this agreement. Based upon the price of the Company’s common stock on December 31, 2018 and June 30, 2018 this Note is convertible into approximately 114,066,667 and 107,516,667 shares of common stock, respectively.

Judgement Settlement Agreement

The Company entered into a “Judgment Settlement Agreement” effective December 10, 2018 by and between John M. Fife, an individual (“Lender”), and mPhase Technologies, Inc. The Judgment Settlement Agreement, supersedes all other prior oral or written agreements between Borrower, as further detailed in our Filing on form 8-k on December 21, 2018.

The agreement required a $15,000 execution payment, which we paid in December 2018; and subsequently the agreement offers three payment options- the first two options have material settlements amounts which would be due during the Quarter ending March 31, 2019 -(short term options); Or the 3rd option which calls for $15,000 monthly payments throughout calendar 2019 and a January 15, 2020 lump sum final payment (long term option);

The initial and revised payment schedule of the Judgement Settlement Agreement are as follows:

(a) $15,000, which amount has been paid upon execution of this Agreement, plus (b) either

(short term options);                                                                                                      ( Payment Status)

(i) $265,000, provided such amount is received by Lender on or before January 15, 2019, -(expired)

(ii) $280,000, provided such amount is received by Lender on or before February 15, 2019,-(expired)

iia.);as revised; $15,000 on February 1, 2019; and $270,000 by March 15, 2019 – (the Company is targeting this option)

(long term option); 

iii) $375,000, which amount, if Borrower elects this option, shall be payable as follows:

(1) Borrower shall make a payment to Lender in the amount of $15,000. on or before January 15, 2019, and

(2) Borrower shall continue making payments of $15,000 each month until January 15, 2020, when Borrower shall pay to Lender the entire unpaid portion of the Settlement Amount (which would be equal to $195,000).


3.EQUITY TRANSACTIONS, NOTES PAYABLE AND CONVERTIBLE DEBT – (continued)

Judgement Settlement Agreement – (continued)

During the six months ended December 31, 2018, the Company paid $15,000 applying $8,151 to principle and $6,849 to interest. During the six months December 31, 2018 and 2017 recorded a total of $40,399 and $$36,676 interest expense on the preceding forbearance and current judgement settlement agreement. On December 31, 2018 the judgement settlement agreement, which satisfies the Fife obligation in full, totaled $910,764.

The Company plans to satisfy this agreement in full by completing the short-term option of the Judgement Settlement Agreement of the during the quarter ending March 31, 2019, and has included $300,000 included in the line item “Current Portion, liabilities in arears- Judgement Settlement Agreement” for this agreement and $610,764 in the line item “Long term portion, liabilities in arears- Judgement Settlement Agreement in the liabilities section of the Company’s Balance Sheet as of December 31, 2018.

Had the Company planned to or should we revert to the long-term option of the Judgement Settlement Agreement $180,000 would be included in the line item “Current Portion, liabilities in arears- Judgement Settlement Agreement ” for this agreement and $730,764 in the line item “Long term portion, liabilities in arears- Judgement Settlement Agreement ” in the liabilities section of the Company’s Balance Sheet as of December 31, 2018;

Should the Company satisfy this liability utilizing the short-term option of the Judgement Settlement Agreement we would realize a gain on such settlement of approximately $610,000. Should the Company satisfy this liability utilizing the long-term option of the Judgement Settlement Agreement we would realize a gain on such settlement of approximately $580,000.

Conversion of Related Party and Strategic Vendor Debts

On September 24, 2018 the officers converted $538,777 accrued wages into 5,387,770,000 shares and $702,105 of notes payable and accrued interest into 7,021,050,000 shares and a director converted $186,000 of accrued fees into 1,860,000,000 shares and $126,364 of a note and accrued interest into 1,263,642,700 shares, of the Company’s common stock. Also, on September 24, 2018 accounts payable to strategic vendors totaling $99,500 were converted into 995,000,000 shares of common stock. These conversions were for 100 % of the debt to these individuals owed by Company on December 31, 2017, pursuant to a resolution, of the Company’s Board dated November 28, 2017, issuable when such shares became available, at $.0001 per share,

Effective December 31, 2018 the officers and a Director of the Company converted $133,010 and vendors of the Company converted $15,300 of debt of the Company outstanding on December 31, 2018 into 2,660,200,000 and 306,000,000 shares of common stock at $.00005 per share. These shares were issued as a prerequisite to the Transition Agreement which was part of the “Change in Control Agreements” culminating in the change in the Management of the Company (see Note 8- Subsequent Events). 

Reserved shares

The Company has agreed to reserve newly issued shares of Preferred and Common Stock pursuant to the change in control agreements discussed in “The Transition Agreement” (see note-8 - Subsequent Events)

Preferred Stock

We issued one thousand (1,000) shares of the Company’s recently created new class of Series A Preferred Stock to the Company’s New President and CEO to effectuate voting control of the Company as of January 11, 2019, pursuant to the Transition Agreement.

Common Stock

Signing Shares

The issuance of restricted shares of common stock of the Company equal to 20% or 13,109,494,031, of the number of shares outstanding, after the shares reserved under the agreements (“Signing Shares”) on the Effective Date.

Warrant agreement (s) & warrant cap

A warrant agreement (s) with provisions to acquire up to 80% (the warrant cap) of the Company’s common stock with acceleration provisions;


3.EQUITY TRANSACTIONS, NOTES PAYABLE AND CONVERTIBLE DEBT – (continued)

Settlement and New funding share reserve(s)

The Company has agreed to reserve a total of 15,000,000,000 newly issued shares of Common Stock, of which 2,660,200,000 and 306,000,000 were issued concurrently to reduce liabilities outstanding December 31, 2018, and 9,533,800,000 remained available from the initial share reserve to settle prior liabilities and 2,500,000.000 remained available from the initial share reserve to fund continuing operations as of January 11, 2019; the effective date of implementation of all of the “change in control agreements” discussed herein pursuant to” The Transition Agreement” (see note-8 - Subsequent Events)

  

SETTLEMENT RESERVE

  FUNDING RESERVE 
  Shares of Common
Stock
  Shares of Common
Stock
 
Initial Shares to Establish Reserve  9,839,800,000   2,500,000,000 
         
Shares issued concurrently to transition agreement for the conversion of 75% strategic vendors, outstanding December 31, 2018.  (306,000,000)  - 
Shares available upon execution of The Transition Agreement-January 11, 2019  9,533,800,000   2,500,000,000 
         
Shares issued subsequent to “Change in Control” to accredited investors in private placements through, 2019  (300,000,000)  - 
Shares available per Reserve on February 15, 2019  9,233,800,000   2,500,000,000 

PRIOR LIABILITIES -SETTLEMENT RESERVE

1. 9,839,800,000 shares of Common Stock of the Company to settle the Debts of the Company outstanding December 31, 2018, in the following priority; - The Judgement Settlement Agreement (formerly -Fife forbearance agreement), JMJ Financial, Inc., MH Investment Trust, PowerUp Lending Ltd, as well as other liabilities satisfactory to the Executive and the Company; (as per Section 2 (a) of the Reserve Agreement concurrent “change in control agreements”, dated January 11, 2019);As of the date of this filing 9,233,800,000 shares remain available under this reserve.

OFFICER’S AND DIRECTOR -CONVERSION SHARE RESERVE

2. 2,660,200,000 shares of Common Stock of the Company for the conversion of 75% payables to officers’ and a director outstanding December 31, 2018, (as per Section 2 (a) of the Reserve Agreement concurrent “change in control agreements”, dated January 11, 2019) As of the date of this filing no shares remain available under this reserve.

CONTINUING OPERATIONS SHARE RESERVE

3. 2,500,000,000 shares of common stock as per section 2 (c) to be sold at a price, not less than $.00005 per share in periodic Private Placements, (as per Section 2 (a) of the Reserve Agreement concurrent “change in control agreements”, dated January 11, 2019) As of the date of this filing all of the shares remain available under this reserve.

FINAL ADJUSTMENT FOR LIABILITIES ELIMINATED IN SETTLEMENT RESERVE

To the extent Company does not eliminate the above-mentioned liabilities, or the cost to do so requires more than the funding provided within six months of the Effective Date, the Warrant Cap shall increase be increased by that number of shares at a price of $.00005 which equals the amount of remaining liability.


4.COMMITMENTS

Judgement Settlement Agreement

The Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife discussed above, effective December 10, 2018, by and between John M. Fife, an individual (“Lender”), and mPhase Technologies, Inc; The Company plans to satisfy this agreement in full by completing the short-term option of the Judgement Settlement Agreement;(iia.)whichas revised; the Company has paid $15,000 on February 1, 2019 and would be required to pay $270,000 by March 15, 2019.

Contracts and Commitments Executed Pursuant to the Transition Agreement:

In the transaction whereby, Mr. Bhatnagar acquired control of the Company on January 11, 2019, the Company entered into material commitments including; (see Note 8- Subsequent Events). 

The Company agreed to an employment agreement with the Executive which include annual compensation for a period of five (5) years with annual salary of $275,000; and The issuance of restricted shares of common stock of the Company equal to 20% or 13,109,494,031  of the amount of shares outstanding, after giving effect to the shares reserved under the agreements, (“Signing Shares”) on the Effective Date.; and a warrant agreement (s) with provisions to acquire up to 80% (the warrant cap) of the Company’s common stock with acceleration provisions.

The Company agreed to finalize undertakings already in process to extinguish specific debts and settle or reduce other liabilities outstanding on December 31, 2018, within six (6) months. The result of our settlements, when finalized, will be evaluated based agreed upon limits, and the liabilities may exceed the threshold for agreed upon limits on the quantity of shares issuable under the warrant and warrant cap calculation.

5.CONTINGENCIES

The Company had been in litigation with John Fife with respect to a Convertible Note originally issued on September 13, 2011 in the principal amount of $557,000. Fife sought damages on a Motion for Summary Judgment in the amount in excess of $1,300,000 and attorney’s fees. On December 15, 2014 the federal district court in the North East District of Illinois found in favor of Fife on a motion for Summary Judgment. The Company had entered into a Forbearance Agreement with Fife as a result of negotiations to settle such Judgment. As of December 31, 2018, the Forbearance agreement is no longer in effect and no shares of our common stock are issuable or eligible to be converted to under this obligation as a result of the Judgement Settlement Agreement effective December 10, 2018 discussed below.

Judgement Settlement Agreement

The Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife discussed above, effective December 10, 2018, by and between John M. Fife, an individual (“Lender”), and mPhase Technologies, Inc. The Agreement supersedes all other prior oral or written agreements between Borrower. The Company plans to satisfy this agreement in full by completing the short-term option of the Judgement Settlement Agreement of the during the quarter ending March 31, 2019, which would require us to pay $270,000 by March 15, 2019. If that payment it not paid timely; not withstanding whether or not we can get a revision to the short term option we are pursuing; we may revert to the long-term option of the Judgement Settlement Agreement of which $180,000 would be included in the line item “Current Portion, liabilities in arears- Judgement Settlement Agreement ” for this agreement and $730,763 in the line item “Long term portion, liabilities in arears- Judgement Settlement Agreement ” in the liabilities section of the Company’s Balance Sheet as of December 31, 2018.

Should the Company satisfy this liability utilizing the short-term option of the Judgement Settlement Agreement we would realize a gain on such settlement of approximately $610,000. Should the Company satisfy this liability utilizing the long-term option of the Judgement Settlement Agreement we would realize a gain on such settlement of approximately $580,000. (see also note 3)

Amounts Contingent upon Certain Terms of Change in Control Agreements Effective January 11, 2019 (see note-8 - Subsequent Events)

To the extent Company does not eliminate the certain liabilities within six months of the effective Date, the Warrant Cap shall increase be increased by such number of shares at a price of $.00005 equal to the amount of excess liability.

The Change in Control Agreements, effective January 11, 2019, also have certain provisions that accelerate the warrant and employment agreements.


6.FAIR VALUE MEASUREMENTS

Effective July 1, 2008, we adopted Accounting Standards Codification (“ASC”) 820-10-20, Fair Value Measurements, which provides a framework for measuring fair value under generally accepted accounting principles. ASC 820-10-20 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

ASC 820-10-20 requires820 also describes three levels of inputs that valuation techniques maximize the use of observablemay be used to measure fair value:

Level 1: Observable inputs and minimize the use of unobservable inputs. ASC 820-10-20 also establishes a fair value hierarchy, which prioritizes the valuation inputs into three broad levels. Financial assets and liabilities valued using level 1 inputs are based onthat reflect unadjusted quoted market prices within active markets. Financial assets and liabilities valued using level 2 inputs are based primarily on quoted prices for identical assets or liabilities traded in active markets.

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3: Inputs that are generally unobservable. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

Financial instruments consist principally of cash, accounts receivable, prepaid expenses, due from affiliates, accounts payable, accrued liabilities, due to related parties, and other current liabilities. The carrying amounts of such financial instruments in the accompanying balance sheets approximate their fair values due to their relatively short-term nature. The fair value of short and long-term debt is based on current rates at which the Company could borrow funds with similar remaining maturities. The carrying amounts approximate fair value. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments.

11

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Revenue Recognition

Revenue is derived from the sale of artificial intelligence and machine learning focused technology products. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. In the event any discounts, sales incentives, or similar arrangements are agreed to with a customer, such amounts are estimated at time of sale and deducted from revenue. Sales taxes and other similar taxes are excluded from revenue (see Note 6).

Share-Based Compensation

The Company computes share based payments in accordance with ASC 718-10, Compensation (“ASC 718-10”) and Staff Accounting Bulletin (“SAB”) No. 107, Share-Based Payment No. 107 (“SAB 107”). The Company has applied the provisions of SAB 107 in its adoption of ASC 718-10. The Company accounts for non-employee share-based awards in accordance with ASC Topic 505-50, Equity Based Payments to Non-Employees. The Company estimates the fair value of stock options and warrants by using the Black-Scholes option pricing model.

Derivative Instruments

The Company enters into financing arrangements that consist of freestanding derivative instruments or are hybrid instruments that contain embedded derivative features. The Company accounts for these arrangements in accordance with ASC topic 815, Accounting for Derivative Instruments and Hedging Activities as well as related interpretations of this standard. In accordance with this standard, derivative instruments are recognized as either assets or liabilities in activethe balance sheet and are measured at fair values with gains or inactive markets. For certain long-term debt,losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract are bifurcated and are recognized at fair value with changes in fair value recognized as either a gain or loss in earnings. The Company determines the fair value wasof derivative instruments and hybrid instruments based on presentavailable market data using appropriate valuation models, considering all of the rights and obligations of each instrument.

The Company estimates fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered consistent with the objective measuring fair values. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques (such as Black-Scholes model) are highly volatile and sensitive to changes in the trading market price of the Company’s common stock. Since derivative financial instruments are initially and subsequently carried at fair values, our income (expense) going forward will reflect the volatility in these estimates and assumption changes.

Convertible Debt Instruments

The Company records debt net of debt discount for beneficial conversion features and warrants, on a relative fair value techniques using inputs derived principally or corroborated from market data.basis. Beneficial conversion features are recorded pursuant to the Beneficial Conversion and Debt Topics of the Financial Accounting Standards Board (“FASB”) ASC. The amounts allocated to warrants and beneficial conversion rights are recorded as debt discount and as additional paid-in-capital. Debt discount is amortized to interest expense over the life of the debt.

12

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Income Taxes

The Company accounts for income taxes in accordance with Accounting for Income Taxes, as clarified by ASC 740-10,Accounting for Uncertainty in Income Taxes (“ASC 740”). Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities using level 3 inputs were primarily valued using management’s assumptions aboutand net operating loss and tax credit carryforwards given the assumptions market participants would utilizeprovisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year-to-year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in pricingwhich the assetCompany operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or liability.the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation techniques utilizedallowances are recorded related to determine fair value are consistently applied.deferred tax assets based on the “more likely than not” criteria of ASC 740.

 

Financial instrumentsASC 740 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the “more-likely-than-not” threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company’s tax returns for its June 30, 2019, 2018, 2017, and 2016 tax years may be selected for examination by the taxing authorities as the statute of limitations remains open.

The Company recognizes expenses for tax penalties and interest assessed by the Internal Revenue Service and other taxing authorities upon receiving valid notice of assessments. The Company has received no such notices for the tax years ended June 30, 2019 and 2018.

Earnings Per Share

In accordance with the provisions of FASB ASC Topic 260,Earnings per Share, basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the weighted average number of shares of common stock outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered Level 3 when their values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. Level 3 financial instruments also include those for which the determination of fair value requires significant management judgment or estimation.calculating EPS on a diluted basis.

 

SomeIn computing diluted EPS, only potential common shares that are dilutive, those that reduce EPS or increase loss per share, are included. The effect of contingently issuable shares are not included if the result would be anti-dilutive, such as when a net loss is reported. Therefore, basic and diluted EPS are computed using the same number of weighted average shares for the three and six months ended December 31, 2019 and 2018, respectively, as we incurred a net loss for those periods. At December 31, 2019, there were outstanding warrants to purchase up to approximately 37,000,000 shares of the Company’s common stock, approximately 703,726 shares of the Company’s common stock to be issued, and notes payable held by third parties with convertible features that if converted, would total approximately 1,400,000 shares of the Company’s common stock, which may dilute future EPS. At December 31, 2018, there were notes payable held by third parties and officers and directors, with convertible features that if converted, would total approximately 200,000 shares of the Company’s common stock, which may dilute future EPS.

13

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Recently Adopted Accounting Standards

Effective July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2016-02, Leases (“ASU 2016-02”). The standard amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. The new leases standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. In September 2017, the FASB issued ASU 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842, which amends certain aspects of the new lease standard. The Company determined the adoption of ASU 2016-02 did not have a material impact on its consolidated financial statements.

Effective July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2017-11, Update to Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. The ASU makes limited changes to the guidance on classifying certain financial instruments as either liabilities or equity. The ASU is intended to improve (1) the accounting for instruments with “down-round” provisions and (2) the readability of the guidance in ASC 480 on distinguishing liabilities from equity by replacing the indefinite deferral of certain pending content with scope exceptions. The Company determined the adoption of ASU 2017-11 did not have a material impact on its consolidated financial statements.

Recently Issued Accounting Standards Not Yet Adopted

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement, to modify the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concept Statement, including the consideration of costs and benefits. The standard is effective for the Company as of July 1, 2020, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

In August 2018, the FASB issued ASU 2018-13, to modify the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concept Statement, including the consideration of costs and benefits. The standard is effective for the Company as of July 1, 2020, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on the accompanying consolidated financial statements.

14

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 4: BUSINESS ACQUISITION

On June 30, 2019, the Company acquired 99% of the outstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a suite of commercial data analysis products for use across multiple industries. The Company expects the acquisition to result in synergies with its other operating divisions, which will drive revenue growth and innovation.

The goodwill of $6,020 arising from the acquisition consists largely of the synergies expected from combining the operations of the Company and Alpha Predictions.

The following table summarizes the consideration paid for Alpha Predictions and the fair values of the assets acquired and liabilities assumed recognized at the acquisition date.

Consideration    
Cash $1,438 
Fair value of total consideration transferred  1,438 
     
Recognized amounts of identifiable assets acquired and liabilities assumed    
Cash  3,127 
Accounts receivable  26,155 
Prepaid expenses  7,488 
Property and equipment  11,048 
Intangible asset – purchased software  2,905,668 
Accounts payable  (26,067)
Accrued expenses and other current liabilities  (2,924,288)
Income tax provision, current  (7,713)
Total identifiable net assets  (4,582)
Goodwill $6,020 

The Company is currently evaluating the fair values of the assets acquired and liabilities assumed. The preliminary estimates and measurements are, therefore, subject to change during the measurement period. The acquired intangible asset – purchased software was recognized at fair value as of the acquisition date. It is provisionally subject to a useful life of 3 years, pending further evaluation of the underlying software.

The fair value of the one-percent noncontrolling interest in Alpha Predictions was determined to be immaterial, based on extrapolation of the price paid by the Company for its controlling interest and consideration of any potential control premiums.

15

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 5: INTANGIBLE ASSET – PURCHASED SOFTWARE, NET

Intangible asset – Purchased Software, net, is comprised of the following at:

  December 31,  June 30, 
  2019  2019 
Purchased software $2,925,827  $3,025,801 
Less: accumulated amortization  (484,278)  - 
Purchased software, net $2,441,549  $3,025,801 

Intangible asset – Purchased Software consists of the following two software technologies:

Alpha Predictions purchased software $2,805,860 
Travel Buddhi purchased software  119,967 
Total purchased software $2,925,827 

The Alpha Predictions purchased software was acquired as further described in Note 4. The Travel Buddhi purchased software was acquired on February 15, 2019, for $115,281 and included all rights, software, and code of the technology platform. During the fiscal year ended June 30, 2019, $55,000 of the Travel Buddhi purchase price was paid and $60,281 remained outstanding. At December 31, 2019, the Travel Buddhi technology platform has not been placed in service, but is expected to be during fiscal year 2020.

Purchased software costs are amortized on a straight-line basis over three years. Amortization of purchased software costs is included in general and administration expenses within the consolidated statements of operations.

For the three and six months ended December 31, 2019, amortization expense was $242,139 and $484,278, respectively. There was no amortization expense related to purchased software for the three and six months ended December 31, 2018.

Future amortization expense related to the existing net carrying amount of purchased software at December 31, 2019 is expected to be as follows:

Remainder of fiscal year 2020 $484,311 
Fiscal year 2021  968,622 
Fiscal year 2022  968,622 
Fiscal year 2023  19,994 
  $2,441,549 

16

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 6: REVENUE FROM CONTRACTS WITH CUSTOMERS

The following table presents our revenue disaggregated by category within our single reporting segment:

  For the Three Months Ended  For the Six Months Ended 
  December 31,  December 31, 
  2019  2018  2019  2018 
Subscription $6,180,000  $-  $12,360,000  $- 
Service and support  874,979   -   1,745,068   - 
Application development and implementation  506,988   -   1,026,511   - 
Revenue $7,561,967  $-  $15,131,579  $- 

For the three and six months ended December 31, 2019, the Company was subject to revenue concentration risk as one customer accounted for 99% of our total revenue for both periods.

Subscription and Application Development and Implementation Revenue

The Company recognizes revenue when, or as, it satisfies a performance obligation to a customer. The Company primarily has one performance obligation, which includes the combined promise to develop, implement, and license customized software. Payment terms for the software include one-time application development and implementation fees, which are generally billed on a time-and-materials basis over the development and implementation period, plus fixed license subscription fees, which may either be billed in full upfront or in monthly installments over the license period, which is generally three years. All of these fees are allocated to the single performance obligation of providing software to the customer.

The performance obligation is fully satisfied at the point in time when the customer has taken control of the completed software, which is when physical possession of the software has transferred to the customer, the customer is able to use and benefit from the software, and the contractual license period has begun. Since the Company has no further obligation to the customer once control of the software has transferred, the Company recognizes revenue in full for all of the development and implementation fees at that point in time. Subscription fees are also recognized when control of the software has transferred to the customer but only to the extent such fees are contractually guaranteed to the Company. Any future monthly subscription fees that the Company would not have a contractually guaranteed right to collect in the event of early termination of the contract are instead recognized as revenue on a straight-line basis over the license period.

Service and Support Revenue

Certain contracts also contain a second performance obligation for service and support. This performance obligation includes the promise to provide future updates, upgrades, and enhancements to the software over the license period, if and when they occur. Service and support fees are fixed as a percentage of total contract value and billed in monthly installments over the license period. The Company recognizes service and support fee revenue over time, on a straight-line basis over the license period, as the customer receives such services on a generally uniform basis throughout the license period.

Allocation of the Transaction Price

Prices allocated to each performance obligation generally correspond with the contractually stated prices, since they equal standalone selling price. In some cases, services may be discounted, which requires the company to allocate the transaction price based on relative standalone selling price. The Company estimates standalone selling price based on comparable industry practices and the costs and margins involved in providing services to its customers.

Contract Liabilities

Contract liabilities include amounts billed to the customer in excess of revenue recognized and are presented as contract liabilities on the condensed consolidated balance sheets. At December 31, 2019 and June 30, 2019 contract liabilities totaled $115,166 and $0, respectively.

Practical Expedient

The Company has elected a practical expedient to omit certain disclosures about the transaction price allocated to remaining performance obligations for contracts with terms of one year or less.

NOTE 7: SHORT TERM NOTES PAYABLE

Short term notes payable is comprised of the following:

  December 31,  June 30, 
  2019  2019 
Note payable, John Fife (dba St. George Investors) / Fife Forbearance[1] $784,313  $855,660 
Total short-term notes payable $784,313  $855,660 

[1]effective December 10, 2018, the Company entered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife that was previously in effect. As a result, under the Judgment Settlement Agreement, no shares of the Company’s common stock are issuable or eligible to be converted into. Under the terms of the Judgment Settlement Agreement, the Company is required to pay $15,000 per month from January 15, 2019 through and including February 15, 2020, with a final payment of $195,000 due and payable in March of 2020. The Company has made all payments required as of the date hereof. Failure to make any of the payments, when due, will result in the remaining liability balance of $559,313 (at December 31, 2019), to be immediately due and payable by the Company.

17

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 8:Convertible Debt Arrangements

JMJ Financial

At December 31, 2019 and June 30, 2019, the amount recorded in current liabilities for this one convertible note and accrued interest thereon due to JMJ Financial was $201,148 and $193,287, respectively. During the six months ended December 31, 2019 and 2018 the Company recorded $7,861 and $7,212, respectively of interest for the outstanding convertible note.

As of December 31, 2019 and June 30, 2019, the aggregate remaining amount of convertible securities held by JMJ could be converted into 10,057 and 9,664 shares, respectively, with a conversion price of $20.

Accredited Investors

On June 19, 2019, the Company entered into a Securities Purchase Agreement with an accredited investor (“Lender”) and issued an 8% convertible promissory note in the principal amount of $78,000 to the Lender with a maturity date of June 19, 2020. The Company received net proceeds in the amount of $45,800, with $25,000 refinancing a prior convertible promissory note due to the Lender that had been in default, $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note and $4,200 being paid to the Company’s Transfer Agent to satisfy an outstanding balance. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $103,161, deferred financing costs of $3,000 and debt discount of $75,000. The deferred financing costs and debt discount are being amortized over the term of the note. During December 2019, the Company paid-off the aggregate balance of the convertible promissory note, including accrued interest and prepayment penalty.

On July 30, 2019, the Company entered into a Securities Purchase Agreement with an accredited investor (“Lender”) and issued an 8% Convertible Promissory Note in the principal amount of $53,000 to the Lender with a maturity date of July 30, 2020. The Company received net proceeds in the amount of $50,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $114,380, deferred financing costs of $3,000 and debt discount of $50,000. The deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $53,000 and $1,789, respectively, at December 31, 2019. The aggregate balance of the convertible promissory note, net of deferred financing costs and debt discount at December 31, 2019 was $22,362.

On September 5, 2019, the Company entered into a Securities Purchase Agreement with an accredited investor (“Lender”) and issued an 8% Convertible Promissory Note in the principal amount of $53,000 to the Lender with a maturity date of September 5, 2020. On September 9, 2019, the Company received net proceeds in the amount of $46,800 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note and $3,200 being paid to the Company’s Transfer Agent to satisfy an outstanding balance. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $104,860, deferred financing costs of $3,000 and debt discount of $50,000. The deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $53,000 and $1,359, respectively, at December 31, 2019. The aggregate balance of the convertible promissory note, net of deferred financing costs and debt discount at December 31, 2019 was $16,989.

18

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 8:Convertible Debt Arrangements (continued)

On September 24, 2019, the Company entered into a Securities Purchase Agreement with accredited investors (“Lenders”) and issued 8% Convertible Promissory Notes in the principal amount of $124,200 (including an aggregate of $9,200 in original issue discounts) to the Lenders with maturity dates of September 24, 2020. On September 27, 2019, the Company received net proceeds in the amount of $112,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Notes. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $208,335, original issue discount of $9,200, deferred financing costs of $3,000 and debt discount of $112,000. The original issue discount, deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $124,200 and $2,668, respectively, at December 31, 2019. The aggregate balance of the convertible promissory note, net of original issue discount, deferred financing costs and debt discount at December 31, 2019 was $33,347.

On December 2, 2019, the Company entered into a Securities Purchase Agreement with an accredited investor (“Lender”) and issued an 8% Convertible Promissory Note in the principal amount of $200,000 (including a $7,500 original issue discount) to the Lender with a maturity date of December 2, 2020. On December 2, 2019, the Company received net proceeds in the amount of $182,500 as a result of $10,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note. This convertible debenture converts at the greater of (i) $0.50 per share or (ii) 60% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $200,000, original issue discount of $7,500, deferred financing costs of $10,000 and debt discount of $182,500. The original issue discount, deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $200,000 and $1,271, respectively, at December 31, 2019. The aggregate balance of the convertible promissory note, net of original issue discount, deferred financing costs and debt discount at December 31, 2019 was $15,890.

On December 2, 2019, the Company entered into a Securities Purchase Agreement with an accredited investor (“Lender”) and issued an 8% Convertible Promissory Note in the principal amount of $78,000 to the Lender with a maturity date of December 2, 2020. On December 4, 2019, the Company received net proceeds in the amount of $75,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $78,629, deferred financing costs of $3,000 and debt discount of $75,000. The deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $78,000 and $496, respectively, at December 31, 2019. The aggregate balance of the convertible promissory note, net of deferred financing costs and debt discount at December 31, 2019 was $6,197.

On December 2, 2019, the Company entered into a Securities Purchase Agreement with an accredited investor (“Lender”) and issued an 8% Convertible Promissory Note in the principal amount of $135,000 (including a $6,750 original issue discount) to the Lender with a maturity date of December 2, 2020. On December 3, 2019, the Company received net proceeds in the amount of $122,000 as a result of $6,250 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note. This convertible debenture converts at the greater of (i) $0.50 per share or (ii) 60% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $135,000, original issue discount of $6,750, deferred financing costs of $6,250 and debt discount of $122,000. The original issue discount, deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $135,000 and $858, respectively, at December 31, 2019. The aggregate balance of the convertible promissory note, net of original issue discount, deferred financing costs and debt discount at December 31, 2019 was $10,726.

19

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 8:Convertible Debt Arrangements (continued)

On December 17, 2019, the Company entered into a Securities Purchase Agreement with an accredited investor (“Lender”) and issued an 8% Convertible Promissory Note in the principal amount of $81,000 (including a $6,000 original issue discount) to the Lender with a maturity date of December 17, 2020. On December 17, 2019, the Company received net proceeds in the amount of $73,500 as a result of $1,500 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion. Due to the variable conversion provisions contained in the convertible promissory note, the Company accounted for this conversion feature as a derivative liability. In connection herewith, the Company recorded a derivative liability of $81,599, original issue discount of $6,000, deferred financing costs of $1,500 and debt discount of $73,500. The original issue discount, deferred financing costs and debt discount are being amortized over the term of the note. The aggregate balance of the convertible promissory note and accrued interest was $81,000 and $249, respectively, at December 31, 2019. The aggregate balance of the convertible promissory note, net of original issue discount, deferred financing costs and debt discount at December 31, 2019 was $3,107.

At December 31, 2019 and June 30, 2019, there was $724,200 and $78,000 of convertible notes payable outstanding, net of discounts of $615,582 and $75,649, respectively.

During the six months ended December 31, 2019 and 2018, amortization of original issue discount, deferred financing costs, and debt discount amounted to $184,266 and $0, respectively.

At December 31, 2019, the Company was in compliance with the terms of the Accredited Investors convertible promissory notes.

NOTE 9: DERIVATIVE LIABILITY

The Company evaluates its convertible instruments, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC Topic 815, “Derivatives and Hedging.” The result of this accounting treatment is that the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operation as other income (expense). Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under ASC Topic 815 are reclassified to liabilities at the fair value of the instrument on the reclassification date.

The following table presents a reconciliation of the derivative liability measured at fair value on a recurring basis but are recordedusing significant unobservable inputs (Level 3) from June 30, 2018 to December 31, 2019:

  

Conversion

feature derivative liability

 
June 30, 2018 $- 
Initial fair value of derivative liability recorded as debt discount  75,000 
Initial fair value of derivative liability recorded as deferred financing costs  3,000 
Initial fair value of derivative liability charged to other expense  25,161 
Loss on change in fair value included in earnings  30,508 
June 30, 2019 $133,669 
Initial fair value of derivative liability recorded as debt discount  665,001 
Initial fair value of derivative liability charged to other expense  257,803 
Gain on change in fair value included in earnings  (470,400)
December 31, 2019 $586,073 

20

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 9: DERIVATIVE LIABILITY (continued)

Total derivative liability at amounts that approximateDecember 31, 2019 and June 30, 2019 amounted to $586,073 and $133,669, respectively. The change in fair value included in earnings of $470,400 is due in part to the quoted market price of the Company’s common stock increasing from $0.85 at June 30, 2019 to $0.91 at December 31, 2019, coupled with slightly increased conversion prices due to their liquid or short-term nature, such as cash and cash equivalents, receivables and payables.the effect of “ratchet” provisions incorporated within the convertible notes payable.

 

At December 31, 2018,The Company used the carryingfollowing assumptions for determining the fair value of the notes payable and accrued interest for convertible agreements,instruments granted under the Judgement Settlement Agreement and officers’ notes was approximately $1.150 million. The JMJ convertible notes, which were originally duebinomial pricing model with binomial simulations at various times through December 31, 2012, yield an interest rate of 12%, the Fife Forbearance obligation is 9%. Refer to Note 3 of these unaudited condensed consolidated financial statements for more information about the Company’s notes payable as of December 31, 2018. 2019:

 

7.RELATED PARTY TRANSACTIONS
Expected volatility  162.6% - 357.2%
Expected term  6.9 months - 11.5 months 
Risk-free interest rate  1.59% - 1.60%
Stock price $0.91 

 

MICROPHASE CORPORATIONNOTE 10: STOCKHOLDERS’ EQUITY

 

The total number of shares of all classes of stock that the Company leased office space from Microphaseshall have the authority to issue is 100,001,000 shares consisting of 100,000,000 shares of common stock, $0.01 par value per share, of which 12,667,367 are issued and outstanding and 564,900 are to be issued at its Norwalk location. Microphase also provided certain research and development services and shares administrative personnel from time to time through December 31, 2015. As2019 and 1,000 shares of preferred stock, par value $0.01 per share of which 1,000 shares have been designated as Series A Super Voting Preferred of which 1,000 are issued and outstanding at December 31, 2019.

Common Stock

Private Placements

During the six months ended December 31, 2019, the Company received $197,000 of net proceeds from the sale of 788,000 shares of common stock in private placements with accredited investors, incurring no finder’s fees, of which 530,000 shares of common stock were issued subsequent to December 31, 2019.

During the six months ended December 31, 2018, the Company owed $32,545 to Microphase.

received $30,000 of net proceeds from the issuance of 120,000 shares of common stock in private placements with accredited investors, incurring no finder’s fees.

 

DIRECTORStock Award Payable

 

During the six months ended December 31, 2019, the Company did not issue any shares of common stock to former officers, outside directors, or strategic consultants.

During the six months ended December 31, 2018, three former officers of the Company, Mr. Biderman as an outside Director,director, and certain strategic consultants, who provided services to the Company, received 1,000,000,000a total of 1,150,000 shares of common stock, which waswere valued at $100,000$0.50 or $575,000, based on the closing price of the Company’s common stock on September 24, 2018, and had beenwas included in accrued expenses at June 30, 2018,2018.

Stock Based Compensation

During the six months ended December 31, 2019, the Company issued 231,635 restricted shares of its common stock to Mr. Cutchens, the Company’s Chief Financial Officer, which were granted on June 1, 2019 (the “Grant Date”), pursuant to a resolutionthe terms of an employment agreement with the Company. The restricted shares of common stock vest 25% on the six-month, 1 year, 2 year, and 3 year anniversaries of the Company’s Board dated November 28, 2017, issuable when such shares became available.Grant Date. During the six months ended December 31, 2019, the Company recorded $90,193 of stock-based compensation expense related to the vested portion of this award.

 

In SeptemberDuring the six months ended December 31, 2018, the Company did not issue any common stock to employees or officers or record any stock-based compensation expense.

21

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 10: STOCKHOLDERS’ EQUITY (continued)

Conversion of Service Fees

During the six months ended December 31, 2019, the Company issued 62,000 shares of common stock to a former officer who provided services to the Company.

During the six months ended December 31, 2018, Mr. Biderman, an outside Director’s affiliated firmsformer officers converted $671,787 accrued wages into 1,609,594 shares and $702,105 of Palladium Capital Advisorsnotes payable and Eagle Strategic Advisersaccrued interest into 1,404,210 shares and a director converted $186,000 of accrued fees into 1,860,000,000372,000 shares and $126,364 of a note and accrued interest into 1,263,642,700252,728 shares, of the Company’s common stock. Also, accounts payable to strategic vendors totaling $114,800 were converted into 260,200 shares of common stock.

Reserved Shares

The convertible promissory notes entered into with the accredited investors require the Company to reserve 28,226,605 shares of its Common Stock for potential future conversions under such instruments.

At December 31, 2019, 7,202 shares of the Company’s Common Stock remain subject to be returned to the Company’s treasury for cancellation. Such shares were not sold as part of 8,000 shares of the Company’s Common Stock that was advanced during fiscal year 2014 under an Equity Line of Credit.

Common Stock Warrants

Warrant Agreement – Earned Warrants

Mr. Bhatnagar, the Company’s President and CEO, is entitled to receive warrants to acquire 4% of the outstanding fully diluted common stock of the Company (the “Earned Warrants”) each time the Company’s revenue increases by $1,000,000. The exercise price of the Earned Warrants is equal to $0.50 per share, and he may not receive Earned Warrants to the extent that the number of Signing Shares (as defined in the Warrant Agreement) and Earned Warrants exceed 80% of the fully diluted common stock of the Company (“Warrant Cap”).

Warrant Agreement – Accelerated Warrants

Mr. Bhatnagar, the Company’s President and CEO, shall immediately receive the remaining amount of warrants necessary to acquire up to 80% of the outstanding fully diluted common stock of the Company (“Accelerated Warrants”) when either of the following occur:

a)the Company completes a stock or asset purchase of Scepter Commodities, LLC; or
b)the Company completes a stock or asset purchase of any other entity, either of which, in the aggregate, together with prior revenue increases achieved by the Company, results in the consolidated revenues of the Company being not less than $15,000,000; or
c)the Company grows a similar business organically within mPhase to include contracts generating revenues in excess of $15,000,000; or
d)the Company meets the listing requirements of either the NYSE or NASDAQ

For the six months ended December 31, 2019, since the Company’s revenue was $15,131,579, Mr. Bhatnagar earned warrants to acquire 32,405,058 shares of the Company’s common stock under the provisions of the Warrant Agreement. At December 31, 2019, under the current Warrant Cap, there remains no additional shares of the Company’s common stock that Mr. Bhatnagar can earn.

22

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 10: STOCKHOLDERS’ EQUITY (continued)

For the six months ended December 31, 2019, the Company recognized $16,202,529 of stock-based compensation expense related to the earned warrants, based upon a value of $0.50 per warrant. At December 31, 2019, there remains no additional stock-based compensation expense related to the Warrant Agreement that the Company expects to recognize over the next six months.

The Company estimates the fair value of each option award on the date of grant using a black-scholes option valuation model that uses the assumptions noted in the table below. Because black-scholes option valuation models incorporate ranges of assumptions for inputs, those ranges are disclosed. Expected volatilities are based on the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from certain groups of employees exhibiting different behavior. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The following assumptions were utilized during the six months ended December 31, 2019:

Expected volatility21,779.77%
Weighted-average volatility21,779.77%
Expected dividends0%
Expected term (in years)5.0
Risk-free rate2.52%

The following table sets forth common stock purchase warrants outstanding at December 31, 2019:

  Warrants  Weighted
Average
Exercise Price
  Intrinsic
Value
 
Outstanding, June 30, 2019  4,985,394  $0.50  $       - 
Warrants earned  32,405,058   0.50   - 
Warrants forfeited  -   -   - 
Outstanding, December 31, 2019  37,390,452  $0.50  $- 
             
Common stock issuable upon exercise of warrants  37,390,452  $0.50  $- 

   

Common Stock Issuable Upon Exercise of

Warrants Outstanding

 Common Stock Issuable Upon
Warrants Exercisable
 
Range of
Exercise
Prices
  Number
Outstanding at
December 31, 2019
  

Weighted
Average
Remaining
Contractual
Life (Years)

  

Weighted
Average
Exercise
Price

 Number
Exercisable at
December 31, 2019
  

Weighted
Average
Exercise
Price

 
$0.50   37,390,452   4.80  $0.50  37,390,452  $0.50 
     37,390,452   4.80  $0.50  37,390,452  $0.50 

23

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 10: STOCKHOLDERS’ EQUITY (continued)

Settlement and New Funding Share Reserves

The Company agreed to reserve a total of 3,000,000 shares of its common stock of which 532,040 shares of common stock were reserved for and issued concurrently for the conversion of the Company. Effective75% of outstanding accounts payables to officers’ and a director (discussed below), 1,967,960 shares of common stock were reserved to reduce liabilities outstanding December 31, 2018 this director converted $4,369 of this note into 87,375,000(“Settlement Reserve”), and 500,000 shares of common stock. $1,456stock were reserved to fund continuing operations (“Funding Reserve”). At December 31, 2019, 315,949 shares of common stock remained available from the initial Settlement Reserve to settle prior liabilities and 185,063, shares of common stock remained available from the Funding Reserve to fund continuing operations.

  Settlement Reserve  Funding Reserve 
Initial Shares of Common Stock to Establish Reserve  1,967,960   500,000 
Shares issued concurrently to transition agreement for the conversion of 75% strategic vendors, outstanding December 31, 2018  (61,200)  - 
Shares available upon execution of the Transition Agreement dated January 11, 2019  1,906,760   500,000 
Shares issued subsequent to a “Change in Control” to accredited investors in private placements through December 31, 2019  (1,590,811)  (314,937)
Shares of Common Stock available at December 31, 2019  315,949   185,063 

Prior Liabilities – Settlement Reserve

1,967,960 shares of the Company’s common stock have been reserved to settle the debts of the Company that were outstanding onat December 31, 2018, in the following priority; the Judgement Settlement Agreement (formerly Fife forbearance Agreement), JMJ Financial, Inc., MH Investment Trust, Power Up Lending Ltd, as well as other liabilities satisfactory to the CEO of the Company and the Company (as per Section 2(a) of the Reserve Agreement concurrent with “Change in Control Agreements”, dated January 11, 2019). At December 31, 2019, 315,949 shares of common stock remain available under this reserve category.

Officer’s and Director’s – Conversion Share Reserve

532,040 shares of the Company’s common stock were reserved for the conversion of 75% of payables to officers’ and a director that were outstanding December 31, 2018, (as per Section 2(a) of the Reserve Agreement concurrent with “Change in Control Agreements”, dated January 11, 2019). All these shares were issued effective December 31, 2018 and no shares remain available under this reserve category.

Continuing Operations Share Reserve

500,000 shares of the Company’s common stock were reserved as per Section 2(c) to be sold at a price, not less than $0.25 per share in periodic Private Placements, (as per Section 2(a) of the Reserve Agreement concurrent with “Change in Control Agreements”, dated January 11, 2019). At December 31, 2019, 185,063 shares of common stock remain available under this reserve category.

Final Adjustment for Liabilities Eliminated by Settlement Reserve

On October 9, 2019, the Company and its CEO entered into Amendment No. 1 to the original Reserve Agreement dated January 11, 2019, to extend the date whereby the Company is able to eliminate the above-mentioned liabilities from July 11, 2019 to March 31, 2020. In the event the Company is not able to eliminate the above-mentioned liabilities, or the cost to do so requires more than the funding provided by the Warrant Cap pertaining to Warrants to be issued to Mr. Bhatnagar, the Settlement Reserve shares shall be increased by that number of shares at $0.25, which equals the amount of the remaining liabilities.

Series A Preferred Stock

On January 11, 2019, the Company issued 1,000 shares of Series A Preferred Stock to Mr. Bhatnagar as the Company’s new President and CEO, to effectuate voting control of the Company pursuant to the terms of the Transition Agreement. The Series A Preferred shares were recorded at par value, are not tradeable, and have a nominal liquidation value.

24

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 11: RELATED PARTY TRANSACTIONS

Microphase Corporation

At December 31, 2019, the Company owed $32,545 to Microphase for previously leased office space at its Norwalk location and for certain research and development services and shared administrative personnel from time to time, all through December 31, 2015.

Former Director

On September 24, 2018, a former outside director converted $126,364 of his note payable into 252,728 shares of common stock.

During the six months ended December 31, 2019 and 2018, the Company recorded $0 and $1,915 of accrued interest.

Transactions With Officers

At various points during past fiscal years certain officers and former officers of the Company provided bridge loans to the Company evidenced by individual promissory notes and deferred compensation so as to provide working capital to the Company. All of these notes accrue interest at the rate of 6% per annum, and are payable on demand. During the six months ended December 31, 2019 and 2018, the officers and former officers advanced $48,052 and $42,880 to provide working capital to the Company and $1,447 and $2,294 has been charged for interest on loans from officers and former officers.

At December 31, 2019 and June 30, 2019, these outstanding notes including accrued interest totaled $76,419 and $58,165, respectively. At December 31, 2019, these promissory notes are not convertible into shares of the Company’s common stock.

During the six months ended December 31, 2018, three former officers of the Company, Mr. Biderman as a former outside director, and certain strategic consultants, who provided services to the Company, received a total of 1,150,000 shares of common stock, which were valued at $0.50 or $575,000, based on the closing price of the Company’s common stock on September 24, 2018, and was included in accrued expenses at June 30, 2018.

 

During the six months ended December 31, 2018 and 20172019, the Company recorded $1,915incurred $15,500 of expense related to legal and $3,755 of accrued interest on this loan.

Effective October 1, 2018 the Company reversed to additional paid in capital $7,500 of accrued finders’ fees wavedconsulting services provided by Eagle Strategic Advisers and no amounts remain accrued to this Director’s affiliated firm.


7.RELATED PARTY TRANSACTIONS – (continued)

TRANSACTIONS WITH OFFICERS

Officers of the Company have made working capital loans to the Company from time to time. These loans, together with accrued interest at 6% totaled $42,880 and $777,912 at December 31, 2018 and June 30, 2018, respectively. The Company recorded $2,294 and $20,437 for interest on these loans during the six months ended December 31, 2018 and 2017, respectively.

The Company officers have not accrued salaries since April 2017. During the six months ended December 31, 2018, the three Officers of the Company received 4,000,000,000 shares of common stock which was valued at $400,000 and had been included in accrued expenses at June 30, 2018, pursuant to a resolution ofMr. Smiley, the Company’s Board dated November 28, 2017, issuable when suchformer CFO and legal counsel. During October 2019, the entire balance of $15,500 was converted into 62,000 shares became available.

In September 2018, the officers of the Company converted $538,777 accrued wages into 5,387,770,000 shares and $702,105 of notes payable and accrued interest into 7,021,050,000 shares, of the Company’s common stock.

 

Office Lease

Effective December 31, 2018, the officers ofMay 1, 2019, the Company converted $128,641relocated its corporate office to 9841 Washingtonian Blvd., Suite 390, Gaithersburg, MD 20878, and incurs rent expense of notes$1,350 per month, which is payable and accrued interest into 2,572,825,000 shares, ofto a related party. The lease term with the Company’s common stock.related party is a month-to-month arrangement.

 

8.SUBSEQUENT EVENTS25

 On January 4, 2019, the Company filed an Amendment to its Certificate of Incorporation in the State of New Jersey, pursuant to approval by its Board of Directors, to increase its authorized shares of common stock from 72 billion shares to 125 billion shares of no-par stock. In addition, the Company in such Amendment created a new class of 1000 shares of a Series A super voting preferred Stock.

 

mPHASE TECHNOLOGIES, INC.

The Transition Agreement allows our New Management to develop and implement its current plan of operation while the Company finalizes undertakings already in process to extinguish specific debts and settle or reduce other liabilities outstanding within six (6) months; pursuant to Contracts Executed by the Company, Prior Management and Mr. Bhatnagar whereby Mr. Bhatnagar acquired control of the Company on January 11, 2019.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

 

Significant TermsNOTE 12: COMMITMENTS AND CONTINGENCIES

Commitments

Effective May 1, 2019, the Company relocated its corporate office to 9841 Washingtonian Blvd., Suite 390, Gaithersburg, MD 20878, and incurs rent expense of $1,350 per month, which is payable to a related party. The lease term with the related party is a month-to-month arrangement.

Contracts and Commitments Executed Pursuant to the Transition Agreement:Agreement

(i)Employment Agreement - Under the terms of the Employment Agreement, Mr. Bhatnagar will receive a base salary of $275,000 per annum for a period of five (5) years. As initial compensation, Mr. Bhatnagar shall receive restricted shares of common stock of the Company equal to 20% or 13,109,494,031, of the number of shares outstanding, after giving effect to the shares reserved under the agreements, (“Signing Shares”) on the Effective Date. .

Warrant (s) and Warrant Cap -

(ii)Earned Warrants - Mr. Bhatnagar shall be entitled to receive warrants to acquire 4% of the outstanding fully diluted common stock of the Company (the “Earned Warrants”) each time the Company’s revenue increases by $1,000,000. The exercise price of the Earned Warrants shall be equal to .0001/share and the executive may not receive shares whereby Signing Shares and Earned Warrants exceed 80% of the fully diluted common stock of the Company (“Warrant Cap”).

(iii)Accelerated Warrants– Mr. Bhatnagar shall immediately receive the remaining amount of warrants necessary to acquire up to 80% of the outstanding fully diluted common stock of the Company (“Accelerated Warrants”) when Executive either:

a. - completes a stock or asset purchase of Scepter Commodities LLC or

b. - a stock or asset purchase of any other entity, either of which, in the aggregate, together with prior revenue increases achieved by the Company, shall result in the consolidated revenues of the Company being not less than $15,000,000 or

c. - growing a similar business organically to include contracts generating revenues in excess of $15,000,000 or

d. - The Company meets the listing requirement of either the NYSE or NASDAQ on the filing of a Form 10Q.

(iv)Board and Managements Transition Period Operational Guidelines:

The Transition Agreement provides for changes in the Board of Directors of the Company and the authorization of a new class of Preferred Stock. Bhatnagar will be issued one thousand (1,000) shares of the Company’s recently created new class of Series A Preferred Stock to effectuate voting control of the Company on January 11, 2019.  Mr. Bhatnagar is also the President and CEO of Verus International, Inc., (F/K/A, REAL BIZ MEDIA GROUP), a publicly-held company.


8.SUBSEQUENT EVENTS – (continued)

(v)Reserved Shares - The Company has agreed to reserve a total of 15,000,000,000 newly issued shares of Common Stock; of which:

a. - The Company reserved 9,839,800,000 shares of Common Stock of the Company to extinguish specific debts and settle or reduce other liabilities outstanding within six (6) months to the satisfaction of the Executive and the Company; The Company issued 306,000,000 shares of Common Stock for the conversion of 75% payables to strategic vendors outstanding as of December 31, 2018 under this reserve, concurrently, upon execution of the agreement.

b. - The Company reserved and issued 2,660,200,000 shares of Common Stock of the Company for the conversion of 75% payables to officers’ and a director outstanding as of December 31, 2018 under this reserve, concurrently, upon execution of the agreement.

c. - 2,500,000,000 shares of common stock to be sold at a price, not less than $.00005 per share in periodic Private Placements, pursuant to Section 4(a)(2) of the Act, to pay ongoing operations of the Company through December 31, 2019.

d. - Final adjustment for liabilities eliminated- To the extent Company does not eliminate the above-mentioned liabilities within six months of the Effective Date, the Warrant Cap shall increase be increased by that number of shares at a price of $.00005 which equals the amount of the remaining liability.

(vi)Registration - Mr. Bhatnagar agrees that not later than 90 days from the date hereof under the supervision of Mr. Ronald Durando, on behalf and at the expense of the Company, will cause the Company to draft and file with the Securities and Exchange Commission a Registration Statement on Form S-1 registering all of the shares of Common Stock of the Company held by the prior officers, directors, consultants and Related Parties.

Issuance of Common Stock to accredited investors in private placements subsequent to January 1, 2019

From January 1, 2018 through the January 10, 2019 the Company issued 200,000,000 shares of its common stock in private placements pursuant to Section 4(a)(2) of the Securities Act of 1933 raising gross proceeds of $10,000 which was used for working capital and general corporate purposes.
From January 11, 2018 (“change in control date”) through the date hereof, the Company issued 300,000,000 shares of its common stock in private placements pursuant to Section 4(a)(2) of the Securities Act of 1933 raising gross proceeds of $15,000 which was used for working capital and general corporate purposes.

Changes in Managementsubsequent to January 1, 2019

Effective January 11, 2019, the Board of Directors of mPhase Technologies, Inc. (the “Company”). elected Mr. Anshu Bhatnagar as new members of the Board of Directors of the Company pursuant to Section 14A-5 of the New Jersey Business Corporation Act. Immediately thereafter, Messrs. Abraham Biderman, Mr. Victor Lawrence, Mr. Gustave Dotoli and Mr. Martin Smiley each resigned as a member of the Board of Directors of the Company and Messrs. Durando, Dotoli and Smiley resigned as Officers of the Company.

Effective January 28, 2019, Mr. Smiley returned as interim Chief Financial Officer of the Company.


ITEM 2.MANAGEMENT’S DISCUSSION OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS

The following is management’s discussion and analysis of certain significant factors which have affected mPhase’s financial position and should be read in conjunction with the accompanying financial statements, financial data, and the related notes.

CAUTIONARY STATEMENT PURSUANT TO SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995:

Some of the statements contained in or incorporated by reference in this Form 10-Q discuss the Company’s plans and strategies for its business or state other forward-looking statements, as this term is defined in the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “estimate,” “expect,” “plan,” “intend,” “should,” “seek,” “will,” and similar expressions are intended to identify these forward-looking statements but are not the exclusive means of identifying them. These forward-looking statements include, among others, statements concerning the Company’s expectations regarding its working capital requirements, gross margin, results of operations, business, growth prospects, competition and other statements of expectations, beliefs, plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. Any forward-looking statements contained in this Quarterly Report on Form 10-Q are subject to risks and uncertainties that could cause actual results to differ materially from those results expressed in or implied by the statements contained herein.

LIMITED OPERATIONS OVERVIEW

mPhase Technologies, Inc. (the “Company” or “We”) was organized on October 2, 1996 (OTC Pink Sheets: XDSL.OB) and we have developed various technological products and processes culminating in our present intellectual property portfolio discussed further our form 10-K for the Year End June 30, 2018, on page 12 under the caption, “Patents and Licenses”. In April of 2016 the outgoing management determined to discontinue the Jump Starter line of products, we have had limited operations dedicated to protecting our technology processes; and recapitalizing the Company. During our last two Fiscal Years- June 30, 2018 and 2017, we have focused our operating activity primarily implement a plan to monetize its existing intellectual property portfolio restructuring our debt obligations.  We believe by obtaining on December 10, 2018 an amendment to the Judgment Settlement Agreement with John Fife we have enhanced the opportunity to Complete our Debt restructuring. On January 11, 2019, the Company executed contracts including a “Transition Agreement”, together with our Prior Management and Mr. Bhatnagar whereby Mr. Bhatnagar acquired control of the Company.

The “Transition Agreement” provides the protocol that allows our New Management to review our intellectual property portfolio, and implement its current plan of operation while the Company finalizes undertakings already in process to extinguish specific debts and settle or reduce other liabilities outstanding within six (6) months; and to be in a position to implement a plan to monetize our technology; and transitioning from the Outgoing Management’s plan to reduce liabilities to an acceptable level, and get current on all Periodic Reports required by the Commission and Corporate Federal and State tax filings and streamline internal financial information, as well as update to best practices for our corporate governance and our subsidiaries The foregoing will allow us to evaluate, formulate and implement a revised plan of operation for our next course of action, based upon the status of each potential application of our legacy intellectual property portfolio; estimated cost, time frames to get to deployment, amongst- other factors Outgoing Management may consider relevant, as ultimately determined by the New Management of the Company, including:

- Capitalize on its existing intellectual property portfolio and endeavor to further develop new “smart surface” products through the sciences of microfluidics, micro-electromechanical systems (MEMS) and nanotechnology.

- Continue, with Co-ventures or internally, the development of our patented Drug Delivery Systems.

Commercializing our first nanotechnology-enabled product for military and commercial applications - the Smart NanoBattery providing Power on Command™. Our patented and patent-pending battery technology, based on the phenomenon of electrowetting, offers a unique way to store energy and manage power that could revolutionize the battery industry. Features of the Smart NanoBattery include potentially infinite shelf life, environmentally friendly design, fast ramp to power, programmable control, and direct integration with microelectronic devices.

- Evaluated alternative applications arising from our investment made to development of innovative power cells and related products through the science of microfluidics, microelectromechanical systems (MEMS) and nano- technology, expanding on the one version of the lithium battery based on a breakable separator was developed for an emergency reserve flashlight application.

Our New Management may implement the foregoing directly in mPhase or through one of our wholly- owned subsidiaries.

 

In addition, Mr. Bhatnagar intends to broaden the Company’s existing lines of business in order to accelerate revenue growth.


FINANCIAL OVERVIEW

Continuing Operations

General and administrative. General and administrative expenses consist primarily of fees to third parties and related expenses for investor information and administration of our responsibilities to our shareholders. The Company has faced significant financial challenges since 2016 to maintain its active operations Owing to our large number of our shareholders; we were permitted to voluntarily withdraw in August of 2016 from registration and reporting requirements as a public company as requested on our Form 15-12G. We had considered this course of action in order to save the Company the quarterly costs to pay its auditors to remain public. On November 3, 2016 we engaged a new independent registered public accounting firm and undertook a successful effort to become current with respect to our Periodic Reports with the SEC. Additionally, we have become current with all of Corporate Federal and State tax filings for mPhase and are in the process to become current in such tax filings for all of our subsidiary, companies. We also made arrangements with strategic vendors and have become more current with several vendors and cost centers, including our financial printer, transfer agent costs, office expenses, legal fees and our outside auditors & accounting consultants. Certain administrative activities are outsourced. The Company further conserved financial resources as we recorded no salaries for the three officers of the Company in in any of the periods presented herein.

Other Income (Expense). Included in Other (Income) Expense are recurring items such as interest are non-recurring items related which have in the past (and may be required to going forward for the warrant agreements pursuant to the transition agreementtransaction whereby, Mr. Bhatnagar acquired control of the Company on January 11, 2019, ( see note 8-Subsequent Events) the change in the estimated value of derivative liabilitiesCompany entered into material commitments including an employment agreement and amortization as related debt discount, if any. Also included in other income are gains from debt extinguishments. Such amounts will fluctuate significantly and should not be considered as recurring or in any way indicative of operating results.a warrant agreement (see Note 10).

Discontinued OperationsContingencies

 

Discontinuance of Jump Starter Products was determined by our Board of Directors during Fiscal Year 2016Judgment Settlement Agreement

 

Commencing in April of 2016,Effective December 10, 2018, the Company began discontinuing its lineentered into a “Judgment Settlement Agreement” to satisfy in full the Forbearance Agreement with Fife that was previously in effect. As a result, under the Judgment Settlement Agreement, no shares of Jump Starter productsthe Company’s common stock are issuable or eligible to be converted into. Under the terms of the Judgment Settlement Agreement, the Company is required to pay $15,000 per month from January 15, 2019 through and including February 15, 2020, with a final payment of $195,000 due to increased competition and declining margins.payable in March of 2020. The Company has recognized revenuemade all payments required as of the date hereof. Failure to make any of the payments, when due, will result in the remaining liability balance of $559,313 (at December 31, 2019), to be immediately due and payable by the Company (see Note 7).

Should the Company satisfy the liability as described within the Judgement Settlement Agreement above, the Company would realize a gain on its JUMP products whensuch settlement of approximately $560,000.

Amounts Contingent upon Certain Terms of Change in Control Agreements Effective January 11, 2019

To the products were shipped, and title passedextent Company does not eliminate the certain liabilities within six months of the effective date, the Warrant Cap for warrants issued to Mr. Bhatnagar shall increase by such number of shares at a price of $0.25 per share to equal the customer.amount of the remaining liability.

 

The results of discontinued operations include specifically identifiedChange in bothControl Agreements, effective January 11, 2019, also have certain provisions that may accelerate the 2018 and 2017 periods are allocated to general and administrative expenseswarrant “earn out” formula contained in the December 2017 period.Transition Agreement.

26

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

 

SellingNOTE 13: DISCONTINUED OPERATIONS

The Company has classified the operating results and Marketing Expenses. Sellingassociated assets and marketing expenses consist primarilyliabilities from its Jump line of fees to third parties related to customer service response costs and warranty inquiriesproducts, which ceased generating material revenue during the first quarter of fiscal year 2017, as discontinued operations in the consolidated financial statements for products from our discontinued Jump Starter product line. We have incurred no selling and marketing expenses during the six months ended December 31, 20182019 and nominal selling2018.

The assets and marketing expenses forliabilities associated with discontinued operations included in our consolidated balance sheets were as follows:

  December 31, 2019  June 30, 2019 
  Discontinued  Continuing  Total  Discontinued  Continuing  Total 
Assets                        
Current Assets                        
Cash $-  $106,079  $106,079  $-  $33,996  $33,996 
Accounts receivable, net  -   6,580,980   6,580,980   -   2,526,155   2,526,155 
Prepaid expenses  -   2,180   2,180   -   8,820   8,820 
Total Current Assets  -   6,689,239   6,689,239   -   2,568,971   2,568,971 
Property and equipment, net  -   10,669   10,669   -   11,048   11,048 
Goodwill  -   6,020   6,020   -   6,020   6,020 
Intangible asset - purchased software, net  -   2,441,549   2,441,549   -   3,025,801   3,025,801 
Other assets  -   8,761   8,761   -   3,058   3,058 
Total Assets $-  $9,156,238  $9,156,238  $-  $5,614,898  $5,614,898 
                         
Liabilities                        
Current Liabilities                        
Accounts payable $82,795  $1,797,065  $1,879,860  $82,795  $366,274  $449,069 
Accrued expenses  -   4,538,949   4,538,949   -   3,368,801   3,368,801 
Contract liabilities  -   115,166   115,166   -   -   - 
Due to related parties  -   88,072   88,072   -   65,459   65,459 
Notes payable to officers  -   26,006   26,006   -   25,251   25,251 
Convertible notes payable, net  -   108,618   108,618   -   2,351   2,351 
Liabilities in arrears with convertible features  -   109,000   109,000   -   109,000   109,000 
Liabilities in arrears - judgement settlement agreement (Note 7)  -   784,313   784,313   -   855,660   855,660 
Derivative liability  -   586,073   586,073   -   133,669   133,669 
Total Current Liabilities $82,795  $8,153,262  $8,236,057  $82,795  $4,926,465  $5,009,260 

27

mPHASE TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019 AND 2018

(UNAUDITED)

NOTE 13: DISCONTINUED OPERATIONS (continued)

For the three and six months ended December 31, 2017, most2019, there were no revenue or expenses associated with discontinued operations included in our consolidated statements of whichoperations. For the three and six months ended December 31, 2018, the revenue and expenses associated with discontinued operations included in our consolidated statements of operations were incurred during the first quarter of that period, which represented the completion of the year subsequent to our last sales from this product line.as follows:

  For The Three Months Ended 
  December 31, 2018 
  Discontinued  Continuing  Total 
Revenue $-  $-  $- 
Cost of revenue  -   -   - 
Gross Profit  -   -   - 
Operating Expenses:            
Software development costs  -   -   - 
General and administrative  -   54,754   54,754 
Total Operating Expenses  -   54,754   54,754 
Operating loss  -   (54,754)  (54,754)
Other Income (Expense):            
Interest expense  (5,631)  (24,675)  (30,306)
Gain on extinguishment of debts  12,533   16,278   28,811 
Total Other Income (Expense)  6,902   (8,397)  (1,495)
Income (loss) before income taxes  6,902   (63,151)  (56,249)
Income taxes  -   -   - 
Net income (loss) $6,902  $(63,151) $(56,249)

  For The Six Months Ended 
  December 31, 2018 
  Discontinued  Continuing  Total 
Revenue $-  $-  $- 
Cost of revenue  -   -   - 
Gross Profit  -   -   - 
Operating Expenses:            
Software development costs  -   -   - 
General and administrative  -   119,223   119,223 
Total Operating Expenses  -   119,223   119,223 
Operating loss  -   (119,223)  (119,223)
Other Income (Expense):            
Interest expense  (23,441)  (140,041)  (163,482)
Gain on extinguishment of debts  12,533   16,278   28,811 
Total Other Income (Expense)  (10,908)  (123,763)  (134,671)
Loss before income taxes  (10,908)  (242,986)  (253,894)
Income taxes  -   -   - 
Net loss $(10,908) $(242,986) $(253,894)

NOTE 14: SUBSEQUENT EVENTS

 

GeneralSubsequent to December 31, 2019, the Company issued 530,000 shares of common stock to accredited investors who invested an aggregate of $132,500 through private placements during December 2019.

From January 1, 2020 through February 18, 2020, the Company received $150,000 of net proceeds from the issuance of 220,580 shares of common stock to accredited investors.

On January 9, 2020, the Company entered into a Securities Purchase Agreement with an accredited investor (“Lender”) and administrative. Generalissued an 8% Convertible Promissory Note in the principal amount of $110,000 (including a $5,000 original issue discount) to the Lender with a maturity date of January 9, 2021. On January 13, 2020, the Company received net proceeds in the amount of $100,000 as a result of $5,000 being paid to reimburse the Lender for legal and administrative expenses consist primarilydue diligence fees incurred with respect to this Securities Purchase Agreement and Convertible Promissory Note. This convertible debenture converts at a fixed price of $0.50 per share, subject to adjustment.

On January 21, 2020, the Company entered into a Securities Purchase Agreement with an accredited investor (“Lender”) and issued an 8% Convertible Promissory Note in the principal amount of $68,000 to the Lender with a maturity date of January 21, 2021. On January 23, 2020, the Company received net proceeds in the amount of $65,000 as a result of $3,000 being paid to reimburse the Lender for legal and due diligence fees incurred with respect to third partiesthis Securities Purchase Agreement and Convertible Promissory Note. This convertible debenture converts at 62% of the lowest trading price during the 20 days prior to conversion.

28

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the attached unaudited consolidated financial statements and notes thereto, and our audited consolidated financial statements and related expensesnotes for investor informationour fiscal year ended June 30, 2019 found in our Annual Report on Form 10-K filed with the Securities and administration of our responsibilities to our shareholders, including our financial printer, transfer agent costs, office expenses, legal fees and our outside auditors and internal accounting consultants. In addition, the Company from time to time will use outside consultantsExchange Commission (“SEC”) on a project by project basis. Certain administrative activities are outsourced.October 15, 2019.

 

Other Income (Expense). Included in Other (Income) Expense interest expense are non-recurring items including gains from debt extinguishments. Such amounts will fluctuate significantly and should not be considered as recurring or in any way indicative of operating results.Overview

 

22mPhase Technologies, Inc., was incorporated in the state of New Jersey in 1979 under the name Tecma Laboratory, Inc. and has subsequently operated under Tecma Laboratories, Inc., and Lightpaths TP Technologies, Inc., until June 2, 1997 when the Company changed its name to mPhase Technologies, Inc.

 

On January 11, 2019, the Company underwent a major change in management and control. The new management of the Company is positioning the Company to be a technology leader in artificial intelligence and machine learning while enabling a more rapid commercial development of its patent portfolio and other intellectual property. The Company’s goal is to generate significant revenue from its artificial intelligence and machine learning technologies.

On February 15, 2019, the Company acquired Travel Buddhi, a software platform to enhance travel via ultra-customization tools that tailor a planned trip experience in ways not previously available.

On June 30, 2019, the Company acquired 99% of the outstanding common shares of Alpha Predictions LLP (“Alpha Predictions”). Alpha Predictions is an India-based technology company that has developed a suite of commercial data analysis products for use across multiple industries. The Company expects the acquisition to result in synergies with its other operating divisions, which will drive revenue growth and innovation.

 

THREE MONTHS ENDED DECEMBERCritical Accounting Policies and Estimates

The discussion and analysis of the Company’s financial condition and results of operations are based upon its unaudited consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). The preparation of these unaudited consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities. On an on-going basis, management evaluates past judgments and estimates, including those related to bad debts, potential impairment of intangible assets, accrued liabilities and contingencies. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The accounting policies and related risks described in Note 3 above and the Company’s Annual Report on Form 10-K as filed with the SEC on October 15, 2019 are those that depend most heavily on these judgments and estimates. As of December 31, 2018 VS. DECEMBER2019, there had been no material changes to any of the critical accounting policies contained therein.

Results of Operations

Three months ended December 31, 20172019 compared to three months ended December 31, 2018

Continuing Operations

 

Continuing OperationsRevenue

Our revenue increased to $7,561,967 for the three months ended December 31, 2019, compared to $0 for the three months ended December 31, 2018. The increase is the result of expanding upon a new customer agreement entered into during the fourth quarter of fiscal year 2019. Such new customer agreement accounted for 99% of our total revenue during the three months ended December 31, 2019, resulting in a significant risk of customer concentration.

29

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Cost of Revenue

Cost of revenue totaled $5,623,930 for the three months ended December 31, 2019, compared to $0 for the three months ended December 31, 2018. The increase is the result of generating the increased revenue.

General and AdministrativeOperating Expenses. General

Our operating expenses, which include software development costs, salaries and benefits, stock-based compensation, legal and professional fees, and general and administrative expenses chargedincreased to continuing operations were$8,028,452 for the three months ended December 31, 2019, compared to $54,754 for the three months ended December 31, 2018, comparedan increase of $7,973,698. The increase is primarily due to $37,014stock-based compensation expense related to the Company’s Chief Executive Officer and Chief Financial Officer, an increase in general and administrative expenses related to salaries of the new Chief Executive Officer and Chief Financial Officer, coupled with increased operating expenses to support the increased operations of the business, partially offset by lower expenses from prior officers for services rendered.

On a comparative, proforma basis, excluding non-cash stock-based compensation expense related to the Company’s Chief Executive Officer and Chief Financial Officer, our operating expenses increased to $1,665,549 for the three months ended December 31, 2017, an increase of $17,740. The Company did incur additional transfer agent, printer and internal and independent accounting fees, pursuant2019, compared to Outgoing Management’s administrative housekeeping project$54,754 for the three months ended December 31, 2018, that were $42,126 comparedan increase of $1,610,795. The increase is primarily due to $29,395increased operating expenses to support the increased operations of the business, partially offset by lower expenses from prior officers for services rendered.

Other (Expense) Income

Our other expense decreased by $164,049, or 133%, for the three months ended December 30, 2017.31, 2019. The Company recorded no salariesdecrease is primarily the result of a gain on the change in fair value of derivative liability associated with the convertible promissory notes, partially offset by increases in expenses and amortization related to the convertible promissory notes and interest expense.

Net Loss from Continuing Operations

We had a net loss from continuing operations of $5,934,763 for the three officers of the Company in three months ended December 31, 2018 and December 31, 2017 respectively.

Other Income and (Expense). Interest expense charged2019, compared to continuing operations was $24,675a net loss of $63,151 for the three months ended December 31, 2018, as compared to $60,359an increase of $5,871,612. The increase in net loss is primarily driven by the same period of 2017, a decrease of $35,684, of which $ due to substantially lower liability balances on officers’ loans during the December 2018 quarter, due to material conversionsincrease in September 2018,operating expenses, partially offset by increasesthe increase in interest accruals for the “Fife agreements”, The Company has fully amortized the beneficial conversion feature interest expense through the quarter ended September 30, 2018, thus the current Quarter  ended December 31, 2018 has no such expense. The quarter ended December 31, 2017 includes $30,393 beneficial conversion feature interest expense, which represent the balance of thegross profit and decrease in other expense, as disclosed above.

On a comparative, proforma basis, excluding non-cash stock-based compensation expense related to the current quarter.

Net loss.mPhase recorded aCompany’s Chief Executive Officer and Chief Financial Officer, we generated net (loss) of $(63,151)income from continuing operations for the quarter ended December 31, 2018 less $6,902 of income from discontinued operations, resulting in a net (loss) of $(56,249) for the quarter ended December 31, 2018. For the quarter ended December 31, 2017 the Company recorded a (loss) of $(97,373) from continuing operations, offset by $242,100 of income from discontinued operations, resulting in net income of $144,727 for the quarter.

Basic and Diluted Net Income (Loss) per share. This represents basic and diluted net income (loss) from continuing operations and basic and diluted net income (loss) per common share of $(0.00) and $(0.00)$428,140 for the three months ended December 31, 2018 as compared to basic and diluted2019, an increase of $491,291. The increase in proforma net income (loss) from continuing operationsis primarily driven by the increase in gross profit and basic and diluted net income (loss) per common share of $0.00 and $(0.00) fordecrease in other expense, partially offset by the increase in operating expenses.

Discontinued Operations

For the three months ended December 31, 2017. The basic2019 and diluted per share computations2018, there are based upon weighted average common shares outstandingno revenue, cost of 39,585,434,818 and 16,730,533,688 for basic, and 39,585,434,818 and 18,000,000,000 for, diluted during the respective quarters ended December 31, 2018 and 2017.

Discontinued Operations

Selling and Marketing Expenses. Selling and marketingrevenue, operating expenses, were $0 forother income (expense), or net income from discontinued operations comparatives. For the three months ended December 31, 2018, as compared to $670 for the threeincome from discontinued operations was $6,902.

Six months ended December 31, 2017, a decrease of $670. The decrease is attributable2019 compared to the completion of the Company’s efforts to service customers of its line of Jump Products.

General and Administrative Expenses. General and administrative expenses charged to discontinued operations were $0 for the threesix months ended December 31, 2018 compared to $4,561 for the three months ended December 30, 2017, a decrease of $4,561.

Continuing Operations

 

Other Income and (Expense). RevenueInterest expense charged to discontinued operations was $5,631 during the three months ended December 2018 as compared to $10,144 in the same three months of 2017, a decrease of $4,513 due to lower liability balances of interest expense allocated. During the quarter ended December 31, 2018 recorded we recorded $12,533 of gain on debt extinguishments for liabilities of our discontinued operations as compared to $257,475 gain on debt extinguishments during the same period in 2017. The three-month period in 2017 had significant debt extinguishments related accounts payable for a major project that will not be recurring.  

 

Basic and Diluted Net Income (Loss) per share. This represents basic and diluted net income from discontinued operations per common share of $0.00 net incomeOur revenue increased to $15,131,579 for the threesix months ended December 31, 2018 as2019, compared to basic and diluted net income per common share of $0.00$0 for the threesix months ended December 31, 2017.2018. The basic and diluted per share computations are basedincrease is the result of expanding upon weighted average common shares outstanding of 39,585,434,818 and 16,730,533,688 for basic, and 39,585,434,818 and 18,000,000,000 for diluteda new customer agreement entered into during the respective quartersfourth quarter of fiscal year 2019. Such new customer agreement accounted for 99% of our total revenue during the six months ended December 31, 2018 and 2017.2019, resulting in a significant risk of customer concentration.

 

23

30

 

SIX MONTHS ENDED DECEMBER 31, 2018 VS. DECEMBER 31, 2017ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

 

Continuing OperationsCost of Revenue

Cost of revenue totaled $11,330,444 for the six months ended December 31, 2019, compared to $0 for the six months ended December 31, 2018. The increase is the result of generating the increased revenue.

Operating Expenses

General

Our operating expenses, which include software development costs, salaries and Administrative Expenses. Generalbenefits, stock-based compensation, legal and professional fees, and general and administrative expenses chargedincreased to continuing operations were $119,233$19,974,088 for the six months ended December 31, 2019, compared to $119,223 for the six months ended December 31, 2018, comparedan increase of $19,854,865. The increase is primarily due to $71,816stock-based compensation expense related to the Company’s Chief Executive Officer and Chief Financial Officer, an increase in general and administrative expenses related to salaries of the new Chief Executive Officer and Chief Financial Officer, coupled with increased operating expenses to support the increased operations of the business, partially offset by lower expenses from prior officers for services rendered.

On a comparative, proforma basis, excluding non-cash stock-based compensation expense related to the Company’s Chief Executive Officer and Chief Financial Officer, our operating expenses increased to $3,446,430 for the six months ended December 31, due to additional transfer agent, printer and internal and independent accounting fees, pursuant to Outgoing Management’s administrative housekeeping project for and other administrative expenses, pursuant to Outgoing Management’s administrative housekeeping project, which in the current year that were $94,0882019, compared to $54,409 for the same period in the prior year. The fees were unusually high during these six months we incurred fees two annual and four quarterly reports in 2018 compared to only one quarterly report in the preceding period, which was our first with the current registered firm, made it more cost effective for our current firm to perform alternative procedures, which was for the Quarter ended March 31, 2016, filed in November, 2017.The Company recorded no salaries for the three officers of the Company in six months ended December 31, 2018 and December 31, 2017 respectively.

Other Income and Expense. Interest expense charged to continuing operations was $140,041 in the six months in Fiscal 2018 as compared to $123,249 for the prior period, an increase of $16,792, which is affected by two components liability balances. The first six months 2018 the Company included a non-cash gain resulting from the gain on debt extinguishments of $1,051,594 attributed to continuing operations. This resulted from the dismissal of litigation, instituted by a third party, River North Equities (“River North”), for a portion of the JMJ notes (see-Note 3, Arrangement no.#2) had assigned to River North, and in turn River North commenced litigation which was dismissed with prejudice; and the Company was awarded legal fees.

Net loss.mPhase recorded net loss of $242,986 from continuing operations for the six month period ended December 31, 2017, plus $10,908 of loss from discontinued operations, resulting in net loss of $253,894 for the current year as compared to a net income of $1,081,847 in the prior relative period, which consisted of a $855,846 income from continuing operations of $226,001 loss from discontinued operations for the six months ended December 31, 2017. The period income for 2017 was solely attributed to the gain on debt extinguishment.

Basic and Diluted Net Income (Loss) per share. This represents basic and diluted net income (loss) from continuing operations and basic and diluted net income (loss) per common share of $(0.00) and $0.00$119,223 for the six months ended December 31, 2018, as comparedan increase of $3,327,207. The increase is primarily due to basic and diluted net income (loss)increased operating expenses to support the increased operations of the business, partially offset by lower expenses from continuing operations and basic and diluted net income (loss) per common share of $(0.00) and $0.00prior officers for services rendered.

Other (Expense) Income

Our other expense decreased by $56,441, or 46%, for the six months ended December 31, 2017.2019. The basicdecrease is primarily the result of increases in expenses and diluted per share computations are based upon weighted average common shares outstandingamortization related to the convertible promissory notes and interest expense, partially offset by a gain on the change in fair value of 29,049,352,975 and 17,299,797,272 for basic, and 29,049,352,975 and 18,000,000,000 for, diluted duringderivative liability associated with the respective quarters ended December 31, 2018 and 2017.convertible promissory notes.

 

DiscontinuedNet Loss from Continuing Operations

 

Selling and Marketing Expenses. Selling and marketing expenses were $0We had a net loss from continuing operations of $16,240,275 for the six months ended December 31, 2019, compared to a net loss of $242,986 for the six months ended December 31, 2018, comparedan increase of $15,997,289. The increase in net loss is primarily driven by the increase in operating expenses and other expense, partially offset by the increase in gross profit, as disclosed above.

On a comparative, proforma basis, excluding non-cash stock-based compensation expense related to $2,094the Company’s Chief Executive Officer and Chief Financial Officer, we generated net income from continuing operations of $287,383 for the six months ended December 31, 2017, a decrease2019, an increase of $2,094.$530,369. The decreaseincrease in proforma net income is attributable toprimarily driven by the wind-downincrease in gross profit, partially offset by increases in operating expenses and other expense.

Discontinued Operations

For the six months ended December 31, 2019 and 2018, there are no revenue, cost of revenue, operating expenses, other income (expense), or net income from discontinued operations comparatives. For the Company’s efforts to service customers of its line of Jump Products.six months ended December 31, 2018, loss from discontinued operations was $10,908.

Liquidity and Capital Resources

General

At December 31, 2019, we had $106,079 of cash and Administrative Expenses. Generala working capital deficit of $1,546,818 as compared to cash of $33,996 and administrative expenses charged to discontinueda working capital deficit of $2,440,289 at June 30, 2019.

Net cash used in operating activities of continuing operations were $0was $660,849 for the six months ended December 31, 20182019 as compared to $8,863net cash provided by operating activities of continuing operations of $71,050 for the six months ended December 31, 2017, a decrease of $8,863.2018.

31

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

 

Other IncomeWe have financed our operations since inception primarily through proceeds from equity and Expense. Interest expense charged to discontinued operations was $23,441 in the six months ended December 2018 as compared to $20,517 in the same six months in 2017, an increase of $.debt financings. During the six months ended December 31, 2018 the Company recorded $12,5332019, net cash provided by financing activities of gain on debt extinguishments of discontinued liabilities. During the six months ended December 31, 2017 the Company recorded $257,475 of gain on debt extinguishments of discontinued liabilities.

Net loss from Discontinued Operations. mPhase recorded a net loss from discontinuedcontinuing operations of $10,908 for the six months ended December 31, 2018was $699,800, as compared to net income of $226,001 for the six months ended December 31, 2017.

Basic and Diluted Net Income (Loss) per share. This represents basic and diluted net income from discontinued operations per common share of $0.00 net income for the six months ended December 31, 2018 as compared to basic and diluted net income per common share of $0.00 for the six months ended December 31, 2017. The basic and diluted per share computations are based upon weighted average common shares outstanding of 39,585,434,818 and 16,730,533,688 for basic, and 39,585,434,818 and 18,000,000,000 for diluted during the respective quarters ended December 31, 2018 and 2017.


CRITICAL ACCOUNTING POLICIES

The Company’s critical accounting policies are as follows:

Convertible Instruments-The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815.

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments in accordance with EITF 00-19. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional (as that term is described).

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with the provisions of ASC 470 20 “Debt with Conversion Options” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

Transactions With NewManagement

On January 11, 2019 the Company agreed to an employment agreement with Mr. Bhatnagar which includes annual compensation for a period of five (5) years with annual salary of $275,000;

The issuance of restricted shares of common stock of the Company equal to 20% or 13,109,494,031, of the number of shares outstanding, after giving effect to the shares reserved under the agreements, (“Signing Shares”) on the Effective Date to Mr. Bhatnagar.;

A warrant agreement (s) with provisions to acquire up to 80% (the warrant cap) of the Company’s common stock based upon the Company increasing revenues’;


TRANSACTIONS WITHOutgoing Management

TRANSACTIONS WITH OFFICERS

The officers of the Company have made working capital loans to the Company from time to time. These loans, together with accrued interest at 6% totaled $42,880 and $777,912 at December 31, 2018 and June 30, 2018, respectively. The Company recorded $2,294 and $20,437 for interest on these loans during the six months ended December 31, 2018 and 2017, respectively.

The Company have not accrued officers’ salaries since April 2017. During the six months ended December 31, 2018, the three Officers of the Company received 4,000,000,000 shares of common stock which was valued at $400,000 and had been included in accrued expenses at June 30, 2018, pursuant to a resolution of the Company’s Board dated November 28, 2017, issuable when such shares became available.

In September 2018, the officers of the Company converted $538,777 accrued wages into 5,387,770,000 shares and $702,105 of notes payable and accrued interest into 7,021,050,000 shares, of the Company’s common stock. Effective December 31, 2018, the officers of the Company converted $128,641 of notes payable and accrued interest into 2,572,825,000 shares, of the Company’s common stock.

DIRECTOR

Mr. Biderman received 1,000,000,000 shares of common stock which was valued at $100,000 and had been included in accrued expenses at June 30, 2018, pursuant to a resolution of the Company’s Board dated November 28, 2017, issuable when such shares became available.

In September of 2018, Mr. Biderman, an outside Director’s affiliated firms of Palladium Capital Advisors and Eagle Strategic Advisers converted $186,000 of accrued fees into 1,860,000,000 shares and $126,364 of a note and accrued interest into 1,263,642,700 shares of common stock of the Company. Effective December 31, 2018, this director converted $4,369 of this note into 87,375,000 shares of common stock. $1,456 remained outstanding on December 31, 2018. During the six months ended December 31, 2018 and 2017 the Company recorded $1,915 and $3,755 of accrued interest on this loan

Effective October 1, 2018 the Company reversed to additional paid in capital $7,500 of accrued finders’ fees waved by Eagle Strategic Advisers and no amounts remain accrued to this Director’s affiliated firm.


LIQUIDITY AND CAPITAL RESOURCES

The Company has incurred cumulative losses totaling ($211,932,586) and has a working capital deficit of ($1,131,666) as of December 31, 2018 compared to working capital deficit a of ($3,992,269) as of June 30, 2018, an improvement of $2,861,603 as result of material debt conversions by officers; a director and strategic vendors, as well as further reductions in liabilities and continued debt extinguishments and settlements (“Debt Restructurings”).

The auditors’ report for the fiscal year ended June 30, 2018 includes the statement that “there is substantial doubt of the Company’s ability to continue as a going concern”. As of December 31, 2018, the Company had a negative net worth of ($1,741,630) compared to a negative net worth of ($3,992,469) as of June 30, 2018, primarily because of progress with our Debt Restructurings.

LIMITED FUNDING and OPERATIONS - SIX MONTHS ENDED DECEMBER 31, 2018 and 2017

Cash used in operating activities

Cash used in operating activities was $(104,044)$104,131 during the six months ended December 31, 2018. During such period,Our continued operations primarily depend upon our ability to raise additional capital from various sources including equity and debt financings, as well as our revenue derived from operations. We can give no assurances that any additional capital that we are able to obtain will be sufficient to meet our needs or will be on favorable terms. Based on our current plans, we believe that our cash provided from the cash used byabove sources may not be sufficient to enable us to meet our planned operating activities consisted principally of the net lossneeds for the six months endednext twelve months.

We believe that private placements of our common stock and convertible debt to be issued from time to time will fund our short-term capital needs. At December 31, 2018; of ($253,894) subtracting the non-cash gain on debt extinguishments $28,811, reduced by an increase of $81,351 of accounts payable and accrued expenses; and further reduced by debt amortization of $6,133 and beneficial conversion interest expense of $91,177.

Cash used in operating activities was $(50,404) during the six months ended December 31, 2018. During the same period in 2017, the cash used by operating activities consisted principally of the net income for the six months ended December 31, 2017of $1,081,847 subtracting back the non-cash gain on debt extinguishments of $1,307,069; decreasing cash used by the increase accounts payable and accrued expenses of $110,548 and further reduced by debt amortization of $5,284 and, beneficial conversion interest expense compensation of $60,785.

27

Proceeds from issuance of common stock

During the six months ended December 31, 2018 and 2017, the Company issued 600,000,000 and 300,000,000 shares of its common stock in connection with private placements pursuant to Section 4(a) (2) of the Securities Act of 1933, as amended, raising gross proceeds of $30,000 and $15,000. The proceeds were used by the Company as working capital.

Proceeds from notes payable - related parties

During the six months ended December 31, 2018 and  2017, the Company’s Officers’ and a Director loaned the Company approximately $82,620 and $30,170, net of repayments during those periods, providing the funding needed to assist with the Company’s efforts to bring its filings current and settle its operating debts, when at that time funding via the issuance of common stock was either not available or unfavorably dilutive.

Conversion of Prior Management and Strategic Vendor Debts during the six months ended December 31, 2018

On September 24, 2018 the officers converted $538,777 accrued wages into 5,387,770,000 shares and $702,105 of notes payable and accrued interest into 7,021,050,000 shares and a director converted $186,000 of accrued fees into 1,860,000,000 shares and $126,364 of a note and accrued interest into 1,263,642,700 shares, of the Company’s common stock. Also, on September 24, 2018 accounts payable to strategic vendors totaling $99,500 were converted into 995,000,000 shares of common stock. The September conversions were for all debt owed these individuals by as of December 31, 2017, at $.0001 per share, Effective December 31, 2018 the officers and a Director of the Company converted $133,010 and vendors of the Company converted $15,300 of debt of the Company outstanding on December 31, 2018 into 2,660,200,000 and 306,000,0002019, we had 100,000,000 authorized shares of common stock at $.00005 per share.of which 12,667,367 shares were outstanding and 564,900 shares were to be issued.

 

Debts Conversions by Management and Strategic Vendors
for the six months ended December 31, 2018 are summarized as follows:
       
Liability Category Converted - Management and Strategic Vendors Shares of Common Stock  $ Amount of Liabilities 
Conversion of accrued wages Officers’  5,387,770,000  $538,777 
Conversion of Officers’ loans and accrued interest  9,593,875,000  $830,746 
Conversion of accrued fees to a Director  186,000,000  $186,000 
Conversion of loans and accrued interest due to a Director  1,351,017,700  $130,733 
Conversion of accounts payable to strategic vendors  1,301,000,000  $114,800 
Totals conversions to Common Stock for Debts to Prior Management and Strategic Vendors of the Company for the Six Months Ended December 31, 2018  17,819,662,700  $1,801,056 

Judgement Settlement Agreement (Formerly Fife Forbearance Obligation)

On December 31, 2018, the judgement settlement agreement, which satisfies the Fife obligation in full, totaled $910,764. During the six months ended December 31, 2018 Company paid $15,000 applying $8,151 to principle and $6,849 to interest. During the six months December 31, 2018 and 2017 recorded a total of $40,399 and $36,676 interest expense on the preceding forbearance and current judgement settlement agreement.


The Company plansexpects to satisfy this agreement in full by completing the short-term option of the Judgement Settlement Agreement of thecontinue generating revenues during the quarter ending March 31,fiscal year beginning July 1, 2019 from its artificial intelligence and has included $300,000 included in the line item “Current Portion, liabilities in arears- Judgement Settlement Agreement” for this agreement and $610,763 in the line item “Long term portion, liabilities in arears- Judgement Settlement Agreement in the liabilities section of the Company’s Balance Sheet as of December 31, 2018.

Should the Company satisfy this liability utilizing the short-term option of the Judgement Settlement Agreement we would realize a gain on such settlement of approximately $610,000. Should the Company satisfy this liability utilizing the long-term option of the Judgement Settlement Agreement we would realize a gain on such settlement of approximately $580,000.

machine learning software platforms. The Company does not expect to derive any material revenue from its nanotechnology product development until after a deployment and custom tailoring of its Smart Nanobattery. This

We have based our estimate on assumptions that may prove to be wrong. We may need to obtain additional funds sooner or in greater amounts than we currently anticipate. Potential sources of financing include strategic relationships, public or private sales of our securities, debt or other sources. We may seek to access the public or private equity markets when conditions are favorable due to our long-term capital requirements. We do not have any committed sources of financing at this time, frameand it is uncertain andwhether additional funding will dependbe available when we need it on the success of the new management team in generatingterms that will be acceptable to us, or at all. If we raise funds by selling additional revenues from new products enabling the Company to significantly improve its overall financial condition.


MANAGEMENT’S PLANS AND CURRENT STATUS

The Company had curtailed its efforts with respect to selling its line of automotive jump starter products owing to increased competition resulting in poor margins because of commodity pricing of such products. The Company has sought to implement alternative products for development from our existing patent portfolio and intellectual property but does not foresee a definitive path to revenues until January 11, 2019, when the Company underwent a major change in management and focus to restructure its business to accelerate the generation of revenue through a combination of raising additional capital to improve its balance sheet and aggressively pursue mergers and acquisitions.

The Company has pursued strategic alternatives to best monetize its remaining patent portfolio restructuring and revising its debt obligations and Capital structure. On various occasions commencing with August 11, 2015 and then January 19, 2016, June 30, 2016, August 18, 2017 and February 16, 2018 the Company entered into an Amendments No. 1 through 5 to the Forbearance Agreement with Mr. Fife; primarily rescheduling the monthly payment schedules. On December 15, 2018, the Company paid $15,000 as the execution payment for the judgement settlement agreement, which satisfies the Fife obligation in full. (SEE NOTE 3 and LIQUIDITY SECTION)

River North Equity, LLC (“River North”); which had purchased notes previously issued to JMJ Financial, commenced a litigation against the Company, which was dismissed with prejudice on April 17, 2017; and additionally, we were awarded attorney’s fees. River North failed to appeal a Judgement in favor of the Company negating such Notes by July 17, 2017 and the Judgement became final. As a result of this proceeding the Company recorded the cancellation of the two notes assigned to River North from JMJ Financial for a total of $693,060 of principal and $358,534 accrued interest thereon. This resulted in a $1,051,594 gain from debt during the six months ended December 31, 2017. The Company been negotiating a settlement for the remaining JMJ notes for an amount less than the $109,000 of principle and $76,733 of accrued interest thereon we have recorded due to JMJ at December 31, 2018. The Company has also been negotiating a settlement for the remaining MH Investment Trust note II (‘MH”) for an amount less than the $3,333 of principle and $3,511 of accrued interest thereon we have recorded due to MH at December 31, 2018.

On December 1, 2017 the Company that as part of our recapitalization of the Company, subject to filing with the Secretary of State of New Jersey of an Amendment to its Certificate of Incorporation increasing its authorized shares of common stock to 72 billion shares, the Board of Directors had approved the granting of a total of 5,750,000,000 shares ofor other securities convertible into common stock, to officers, a director and consultantsthe ownership interest of the Company. This resulted in a $575,000 accrued stock award payable at June 30, 2018. These shares were issued September 24, 2018.

On December 28, 2017 the Company entered into a Letter of Intent with Scepter Commodities LLC, a privately-held company, for Scepter to merge into mPhase wherein shareholders of Scepter would own 80% of the outstanding common stock of the Company with mPhase shareholders owning 20% of the common stock of the combined company.

Effective January 11, 2019 the Company underwent a major change in its management team and focus (See “Subsequent Events”) to accelerate its effort to generate material revenues. Such action is a culmination of efforts, begun by the Company through the original LOI of December 28,2017, to move forward with respect to a restructuring of its balance sheet and broaden its product base.


The Transition Agreement enables our New Management to develop and implement its current plan of operation while the Company finalizes undertakings already in process to extinguish specific debts and settle or reduce other liabilities outstanding within six (6) months:

The Company’s ability to continue as a going concern and its future success is dependent upon its ability to raise capital in the near term to: (1) satisfy its current obligations, including recently amended settlement agreements, (2) continue its plan to align partners or other third parties to underwrite any research and development efforts needed to exploit our existing technological capabilities, or develop new products and (3) allow the successful wide scale development, deployment and marketing of its smart surface products, or any newly developed, acquired or otherwise obtained product or service line of business. There can be no assurance the necessary debt or equity financingstockholders will be available, or if so, on terms acceptablediluted. If we are not able to the Company.obtain financing when needed, we may be unable to carry out our business plan. As a result, we may have to significantly limit our operations and our business, financial condition and results of operations would be materially harmed.

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is not exposed to changes in interest rates as the Company has no debt arrangements and no investments in certain held-to-maturity securities. Under our current policies, we do not use interest rate derivative instruments to manage exposure to interest rate changes. A hypothetical 100 basis point adverse move in interest rates along the entire interest rate yield curve would not materially affect the fair value of any financial instruments at September 30, 2018.ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company we are not required to provide information required by this item.

ITEM 4.CONTROLS AND PROCEDURES

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including the Chief Executive Officerour principal executive officer and Chief Financial Officer,principal financial officer, we have evaluated the effectivenessconducted an evaluation of our disclosure controls and procedures as required by(as defined in Exchange Act Rule 13a-15(b)Rules 13a-15(e) and 15d-15(e)) as of December 31, 2019 to determine whether the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that theseCompany’s disclosure controls and procedures are effective.effective to provide reasonable assurance that the information required to be disclosed in our reports under the Exchange Act, and the rules and regulations thereunder, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.


Based on this evaluation, management concluded that our disclosure controls and procedures were effective as of December 31, 2019.

PART II. OTHER INFORMATIONChanges in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

32

PART II – OTHER INFORMATION

ITEM 1.LEGAL PROCEEDINGS

 

On February 2, 2015 the Securities and Exchange Commission upheld the denial of a corporate action by the Financial Industry Regulatory Authority (FINRA) in connection with the Company’s seeking to reverse split its common stock pursuant to FINRA Rule 6490 (see Securities Exchange Act of 1934 Release No 7418 Admin Proc File No. 3-15130 of February 2, 2015). The action was found as deficient by FINRA on the basis that two corporate officers and directors of the Company had previously entered into a Consent Decree with the SEC in October of 2007 by them when they were previously officers of another company named Packetport.com. Item 1. Legal Proceedings

 

On November 20, 2012, mPhase Technologies, Inc. (the “Company”) formally received an Event of Default and Redemption Notice dated November 16, 2012 with respect to an 8% Convertible Note dated September 13, 2011 issued by the Company to St. George Investments LLC and assigned to John Fife. A lawsuit was commenced in late November in the Federal District Court, Northern District of Illinois Eastern Division by Fife against the Company alleging breach of contract and other actions in connection with the 8% Convertible Note. Fife sought damages on a Motion for Summary Judgment in the amount in excess of $1,300,000 plus attorney’s fees. On December 15, 2014 the federal district court in the North East District of Illinois found in favor of Fife on a motion for Summary Judgment. The Company had entered into a Forbearance Agreement with Fife as a result of negotiations to settle such Judgment. As of December 31, 2018, the Forbearance agreement is no longer in effect and no shares of our common stock are issuable or eligible to be converted to under this obligation as a result of the Judgement Settlement Agreement effective December 10, 2018 discussed further in our form 8-K, filed on December 21, 2018.None.

 

On February 16, 2018 the Company filedItem 1A. Risk Factors.

As a Form 8-K announcing a new Amendmentsmaller reporting company we are not required to the Judgment Settlement Agreement with Fife modifying the payment schedule under such agreement: as further detailed in the filing- Specifically under short term payment options the lender agreed to revise short term option (ii) To: (iia.);as revised; $15,000 on February 1, 2019 which has been paid; and $270,000provide information required by March 15, 2019.this item.


ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Common StockItem 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On December 18, 2018All proceeds received from the Company’s Board approved a resolution to increase the authorized common shares offollowing financings were used by the Company to 125 billion shares of the Company’s common stock no par value.

Preferred Stock

Additionally, on December 18, 2018 the Board approved a new class of 1000 shares of Series A (super voting preferred stock). On January 4, 2019 the State of New Jersey accepted an Amendment to the Company’s Certificate of Incorporation providing for the increase in authorized shares of common stock and the new class of super voting preferred stock.

Private Placementsworking capital needs.

 

During the six months ended December 31, 2018,2019, the Company issued 600,000,000 shares of its common stock in connection with private placements pursuant to Section 4(a) (2) of the Securities Act of 1933, as amended, raising gross proceeds of $30,000. The proceeds were used by the Company as working capital.

During the six months ended December 31, 2017, the Company issued 300,000,00798,000 shares of its common stock in connection with private placements pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, raising gross proceeds of $15,000 and incurring finder’s fees of $1,500. The proceeds were used by the Company as working capital.$199,500.

Stock Award Payable

During the six months ended December 31, 2018, the three Officers of the Company received 4,000,000,000 shares of common stock which was valued at $400,000, Mr. Biderman an outside Director received 1,000,000,000 shares of common stock which was valued at $100,000 and strategic consultants received 750,000,000 shares of common stock which were valued at $75,000, and in total this group received a total of 5,750,000,000 shares of common stock which was valued at $575,000 and had been included in accrued expenses at June 30, 2018, pursuant to a resolution of the Company’s Board dated November 28, 2017, issuable when such shares became available.

Stock Based Compensation

During the six months ended December 31, 2018, the Company did not issue any common stock, other than the shares discussed above whish were awarded in fiscal 2018, warrants or options to employees or officers.

During the six months ended December 31, 2017, the Company did not issue any common stock, warrants or options to employees or officers.

Note Payable, Director

A Director of the Company loaned the Company funds for working capital and through June 30, 2018 $130,274 remained outstanding. On September 24, 2018 and December 31, 2018, this director converted $126,364 and $4,369 of this note into 1,263,642,700 and 87,375,000 shares of common stock. $1,456 remained outstanding on December 31, 2018. During the six months ended December 31, 2018 and 2017 the Company recorded $1915 and $3755 of accrued interest on this loan.

The Company had two separate convertible debt arrangements with independent investors that still, had convertible features as of December 31, 2018.

During the six months ended December 31, 2018 no conversions were made under any Convertible Debentures.

During the six months ended December 31, 2017, no conversions were made under any Convertible Debenture.

33

Arrangement #1 (JMJ Financial, Inc.)

The Company entered into a convertible note on November 17, 2009, in which the Company received a total of $186,000 of proceeds in connection with a new financing agreement with JMJ Financial. This transaction consists of the following: 1) a convertible note in the amount of $1,200,000 plus a one-time interest factor of 12% ($144,000) and a maturity date of September 23, 2012 and (2) a secured promissory note in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000 each) and a maturity date of September 23, 2012 due from the holder of the convertible note, of which the Company received a total of $150,000 of proceeds in connection with the second promissory note under this agreement. At June 30, 2012 this convertible note had $372,060 outstanding which was combined with the April 5, 2010 arrangement with JMJ Financial, Inc. JMJ Financial sold this Note to River North Equity LLC. On December 15, 2009 the Company entered into a new financing agreement with JMJ Financial that consists of the following: 1) a convertible note issued by the Company in the amount of $1,500,000 plus a one-time interest factor of 12% ($180,000) and a maturity date of December 15, 2012 and (2) a secured promissory note in the amount of $1,400,000 plus a one-time interest rate factor of 13.2% ($180,000) and a maturity date of December 15, 2012 due from the holder of the convertible note. To date the Company has received a total of $300,000 cash under this note and has issued no shares of common stock to the holder upon conversions. The Company and the holder entered into a Forbearance Agreement amendment, as amended, and funding and conversions have not occurred since April 2011. As of June 30, 2012, this convertible note had $321,000 outstanding which was combined with the April 5, 2010 arrangement with JMJ Financial, Inc. JMJ Financial also sold this Note to River North Equity LLC.

On April 5, 2010, the Company entered into a financing agreement with JMJ Financial that consists of the following: 1) a convertible note issued by the Company in the principal amount of $1,200,000 plus a one-time interest factor of 12% ($144,000) and a maturity date of December 15, 2012, and (2) a secured promissory note from the holder of the convertible note in the amount of $1,100,000 plus a one-time interest rate factor of 13.2% ($144,000 each) and a maturity date of December 15, 2012. To date the Company has received a total of $100,000 cash under this note and has issued no shares of common stock to the holder upon conversions. The remaining $1,144,000 of cash to be received from the holder plus accrued and unpaid interest is convertible into shares of common stock at the option of the holder. As of June 30, 2012, this convertible note had $109,000 outstanding which was combined with the November 17, 2009 and December 15, 2009 arrangements with JMJ Financial, Inc., for a total of $802,060 for convertible notes. The Company has no promissory notes receivable from JMJ as of June 30, 2012.

In April of 2017, the Company received a judgment from the Federal District Court of Northern Illinois Eastern Division in its favor dismissing a claim by River North Equity which effectively negated two notes River North Equity purchased from JMJ Financial. At June 30, 2017 the amount recorded in Current Liabilities for the two notes and accrued interest thereon subject to the River North Equity claim was $1,046,416. Such amount is included in the amount recorded in Current Liabilities for all three convertible notes and accrued interest thereon previously issued to JMJ Financial which totaled $1,212,940 on that date. River North failed to appeal the Judgement by July 17, 2017 and the Judgement become final. As a result of this proceeding the Company recorded the cancellation of the two notes assigned to River North from JMJ Financial for a total of $693,060 of principal and $358,534 accrued interest thereon. This resulted in a $1,051,594 gain from the debt during the six months ended December 30, 2017.

As of December 31, 2018, and as of June 30, 2018, the aggregate remaining amount of convertible securities held by JMJ could be converted into 46,433,250 and 44,630,000 common shares at the conversion floor price of $.004.

During the six months ended December 31, 2018 and 2017 the Company recorded $7,212and $9,198 interest on this agreement.

At June 30, 2018 the amount recorded in Current Liabilities for all three convertible notes and accrued interest thereon previously issued to JMJ Financial was $109,000 and $69,520, respectively. At December 31, 2018 the amount recorded in Current Liabilities for convertible note plus accrued interest thereon previously issued to JMJ Financial was $109,000 and $76,733 respectively.

Arrangement #2 (John Fife dba St. George Investors)/Fife Forbearance

The Company entered into an amended agreement on June 1, 2012, when principle of $557,500 accrued interest of $66,338 and $95,611 of contractual charges for previous notes with John Fife totaled $719,449; whereby, the Company agreed to make payments of principle and interest of $33,238 per month commencing October 1, 2012 through September 1, 2014 at 8% interest and so long as the payments are not in default then no conversions into the Company’s common stock would be available to the holder.


On November 20, 2012, mPhase Technologies, Inc. (the “Company”) formally received an Event of Default and Redemption Notice dated November 16, 2012 with respect to an 8% Convertible Note dated September 13, 2011 issued by the Company to St. George Investments LLC and assigned to John Fife. The notice included alleged defaults with respect to payments owed by the Company under the Convertible Note and the failure to convert the Note into shares of the Company’s common stock. The alleged amount owed according to the notice at that time was approximately $902,279. This proceeding resulted a Memorandum Opinion and Order which was issued on December 15, 2014 by the United States District Court Northern District of Illinois Eastern Division granting the motion of John Fife, plaintiff (“Plaintiff”), for summary judgment against mPhase Technologies, Inc. (the “Company”) for breach of contract (the “Opinion”). All other claims and counterclaims were dismissed. Effective February 10, 2015, the Company entered into a Forbearance Agreement with the Holder. The agreement provided that the Holder would forego his right to enforce its remedies pursuant to the Judgment, which include demand for immediate payment of approximately $1.6 million, provided the Company satisfy its forbearance obligation of $1,003,943, (after accounting for a payment of $15,000 the Company paid, under the terms of the agreement).

The Forbearance agreement required the Company to place, and the Company had done so, 1,000,000,000 shares in reserve with its transfer agent, to satisfy the conversion provisions for any unpaid monthly cash payments. The original agreement also provided that the Company file a Proxy statement before June 1, 2015 should additional shares be needed for the conversion reserve. The Company has not filed such a proxy statement due to cost prohibitions. As of June 30, 2018, 1,000,000,000 shares have been issued with respect to payment obligations under the forbearance agreement, as amended and no amounts remain, in reserve.

During the year ended June 30, 2018 the Company did not make any repayments to Fife under the Judgment Settlement Agreement, as amended. The value of the forbearance debt obligation on June 30, 2018 was $885,365.

As of, June 30, 2018, this forbearance obligation, as amended, would only be convertible for monthly obligations the Company elects to/or does not pay in cash in part or in full, for: (i) up to 625,000,000 shares, for the satisfaction of the next required monthly payment, and (ii) up to 11, 067, 050, 000 shares of our common stock should the entire obligation be converted. 

As of December 31, 2018, the Forbearance agreement is no longer in effect and no shares of our common stock are issuable or eligible to be converted to under this obligation.

Arrangement #3 (MH Investment trust II)

On August 26, 2014, the Company issued to the MH Investment Trust, a Convertible Note in a Private Placement pursuant to Section 4(2) of the Securities Act of 1933 in which the Company received $40,000 in gross proceeds on September 1, 2014. The instrument is in the principal amount of $40,000 and matured on May 1, 2015. Interest only was payable at the rate of 12% per annum by the Company to the holder until maturity. The instrument is convertible into the Company’s common stock at 60% of the volume weighted average price of the stock based upon the average of the three lowest trading days in the 10day trading period immediately preceding such conversion, or 65 % when the trading price exceeds $.0020 for the five days before such conversion. All proceeds received in connection with the proceeds of the financing used by the Company as working capital.

During the six months ended December 31, 2018 and 2017 the Company recorded $393 and $352 interest on this agreement.

At December 31, 2018 the note balance was $3,333 and accrued interest of $3,511 at 12%, remained due under this agreement. At June 30, 2018 the note balance was $3,333 and accrued interest of $3,118, at 12%; remained due under this agreement. Based upon the price of the Company’s common stock on December 31, 2018 and June 30, 2018 this Note is convertible into approximately 114,066,667 and 107,516,667 shares of common stock, respectively.

Judgement Settlement Agreement

The Company entered into a “Judgment Settlement Agreement” effective December 10, 2018 by and between John M. Fife, and mPhase Technologies The Agreement, supersedes all other prior oral or written agreements between Borrower.

The agreement required a $15,000 execution payment, which we paid in December 2018; and subsequently the agreement offers three payment options- the first two options have material settlements amounts which would be due during the Quarter ending March 31, 2018 -(short term options); Or the 3rd option which calls for $15,000 monthly payments throughout calendar 2019 and a January 15, 2020 lump sum final payment(long term option);


Conversion of Related Party and Strategic Vendor Debts

 On September 24, 2018 the officers converted $538,777 accrued wages into 5,387,770,000 shares and $702,105 of notes payable and accrued interest into 7,021,050,000 shares and a director converted $186,000 of accrued fees into 1,860,000,000 shares and $126,364 of a note and accrued interest into 1,263,642,700 shares, of the Company’s common stock. Also, on September 24, 2018 accounts payable to strategic vendors totaling $99,500 were converted into 995,000,000 shares of common stock. These conversions were for 100 % of the debt to these individuals owed by Company on December 31, 2017, pursuant to a resolution, of the Company’s Board dated November 28, 2017, issuable when such shares became available, at $.0001 per share.

Effective December 31, 2018 the officers and a Director of the Company converted $133,010 and vendors of the Company converted $15,300 of debt of the Company outstanding on December 31, 2018 into 2,660,200,000 and 306,000,000 shares of common stock at $.00005 per share. These shares were issued as a prerequisite to the Transition Agreement which was part of the “Change in Control Agreements” culminating in the change in the Management of the Company (see Note 8- Subsequent Events). 

Reserved shares

The Company has agreed to reserve newly issued shares of Preferred and Common Stock pursuant to the change in control agreements discussed in” The Transition Agreement” (see note-8 - Subsequent Events).

Preferred Stock

Mr. Bhatnagar will be issued one thousand (1,000) shares of the Company’s recently created new class of Series A Preferred Stock.

Common Stock

Signing Shares

The issuance of restricted shares of common stock of the Company equal to 20% or 13,109,494,031 on the Effective Date.;

Warrant agreement (s) and warrant cap

A warrant agreement (s) with provisions to acquire up to 80% (the warrant cap) of the Company’s common stock based upon the generation of new revenues by the Company.


ITEM 3.DEFAULTS UPON SENIOR SECURITIES

Item 3. Defaults Upon Senior Securities

 

None.

ITEM 4.(REMOVED AND RESERVED)

ITEM 5.OTHER INFORMATION

Item 5. Other Information

 

None.

 

ITEM 6.EXHIBITS AND REPORTS ON FORM 8-K

Item 6. Exhibits.

 

1.Form 8K, dated December 21, 2018, announcing an Amendment to a Judgment Settlement Agreement between John Fife and the Company.

2.Form 8K, dated January 4, 2019, announcing the filing of an Amendment to the Company’s Certificate of Incorporation with the State of New Jersey.

3.Form 8K, dated January 14, 2019 approving change in management and control of the Company.

4.Form 8k, dated February 1, 2019, announcing the election of Martin Smiley as interim Chief Financial Officer of the Company

5.Form 8k dated February 11, 2019 announcing a modification to the payment schedule under the Settlement Agreement, as amended, with John Fife.

EXHIBITSExhibit
Number
 Description
   
31.131.1* Certification of Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes - OxleySarbanes-Oxley Act of 2002.2002
31.2* 
31.2Certification of Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes - OxleySarbanes-Oxley Act of 2002.2002
32.1* 
32.1Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - OxleySarbanes-Oxley Act of 2002.
32.2* 
32.2Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - OxleySarbanes-Oxley Act of 2002.

101.INS101.INS* XBRL Instance Document*Document
101.SCHXBRL Taxonomy Extension Schema Document*
101.CAL101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document*Document
101.DEF101.DEF* XBRL Taxonomy Extension Definition Linkbase Document*Document
101.LAB101.LAB* XBRL Taxonomy Extension Label Linkbase Document*Document
101.PRE101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document*Document
101.SCH*XBRL Taxonomy Extension Schema Document

 

*Filed herewith.

*filed herewith.33

SIGNATURES

 

Pursuant to the requirements of the Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 mPHASE TECHNOLOGIES, INC.mPhase Technologies, Inc.
  
 /s/ Anshu Bhatnagar
Dated: Anshu Bhatnagar
Chief Executive Officer (Principal Executive Officer)
February 19, 2019By:/s/ Martin S. Smiley2020
  

Martin S. Smiley

/s/ Christopher Cutchens
Christopher Cutchens
Chief Financial Officer

(Principal Financial and Accounting Officer)
February 19, 2020


34